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GENERAL INTRODUCTION 
Relaxin is a pregnancy-associated polypeptide hormone discovered by Hisaw in 
1926. It is found in several mammalian species including the pig, mouse, rat, and 
guinea pig. Relaxin can be produced during the estrous cycle, pseudopregnancy, 
and pregnancy, and even in the male. In the pig, the secretion or release of relaxin 
increases in late pregnancy and reaches maximal levels just preceding parturition. 
The regulatory mechanisms underlying relaxin secretion are not fully understood, 
especially during late pregnancy. 
The primary physiological actions of relaxin are to prepare birth canal for the 
growth and delivery of the fetus. These actions include (1) growth-promoting effect 
on the uterus and cervix; (2) suppression of the uterine contractile activity; (3) stim­
ulation of cervical dilatation; (4) lengthening of pelvic ligament; and (5) facilitation 
of parturition. It has been reported that relaxin stimulates the growth and develop­
ment of the mammary gland, enhances sperm motility, and acts through the central 
nervous system to regulate pituitary function. 
Less information is available concerning the molecular and cellular mechanisms 
of relaxin action. In most cases, estrogen is required for relaxin to fully exert its 
action in the target tissue. Estrogen has been reported to regulate the number of 
relaxin receptors in the target tissues. The synergistic interactions between relaxin 
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and estrogen are well documented but the properties of this interaction are unknown. 
The objectives of the following studies are to investigate (1) the roles of luteiniz­
ing hormone, prolactin, and insulin-like growth factor I on the regulation of pro­
gesterone and relaxin synthesis and secretion from aging corpora lutea in hysterec­
tomized pigs from days 110 to 116; (2) the effects of relaxin with or without estrogen 
on the growth and development of the uterine cervix; and (3) the role of estrogen on 
the induction of relaxin receptors and the interactive effects of relaxin with ovarian 
steroids on collagen metabolism in cultured uterine cervical cells. 
Review of Literature 
Biology of Relaxin 
Relaxin is a polypeptide hormone discovered by Hisaw (1926) during the study of 
the pelvic girdle modification which mammalian females undergo to facilitate birth of 
their young. Hisaw found that a component of pregnant guinea pig blood serum could 
cause a noticeable relaxation of the interpubic ligaments. Later, a crude aqueous 
extract of corpora lutea from pregnant sows was found to contain the relaxative 
hormone, and it was named relaxin (Fevold et al., 1930). The bioassay used to identify 
and quantitate relaxin's biological activity was based on the degree of expansion of 
the pubic symphysis of estrogen-primed guinea pig, and this led to the definition of 
the guinea pig unit (Steinetz et al., 1960). 
The purification and characterization of porcine relaxin were accomplished by 
Sherwood and 0'Byrne (1974). Soon after this purified hormone was available, the 
primary structures of the A chain (Schwabe et al., 1976) and the B chain (Schwabe et 
al., 1977) of the polypeptide hormone were revealed. The A chain of porcine relaxin 
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consists of 22 amino acids and the B chain 32 amino acids. The two chains are 
covalently liked by two interchain disulfide bonds, and the molecular weight is about 
6,000 Daltons. 
Relaxins are species-specific peptides, but they resemble insulin in size, tertiary 
structure, and mechanisms of cleavage from the primary RNA transcripts (Cast, 
1982). However, only 40 - 48% amino acid sequence homology exists among porcine, 
rat, shark, and human relaxins (Sherwood, 1988). These similarities in their super­
ficial structural features led to the concept that relaxin and the members of insulin 
family of peptides might have evolved from a common ancestral gene (Blundell and 
Humbel, 1980). The other evidence to support this view is the observation that an 
intron separates the coding region of the connecting peptide in the human relaxin 
gene-2 at a position corresponding closely to one of two introns in the human insulin 
gene (Hudson et al., 1984). 
Molecular approaches made possible the isolation and characterization of the 
gene sequence for rat (Hudson et al., 1981), pig (Hudson et al., 1984), and human 
(Hudson et al., 1984) relaxin. The information about amino acid sequence of rat 
and porcine relaxin, as determined by nucleotide sequence analysis of cDNA clones 
(Hudson et al., 1981; Haley et al., 1982), confirmed the earlier findings by protein 
biochemical methods. Synthetic human relaxin produced by recombinant DNA tech­
nology are now available (Johnston et al., 1985). It is revealed that relaxin is first 
synthesized as a 20 kD-preprorelaxin with a long connecting peptide plus a 3 kD 
signal sequences (Cast, 1982). 
The tissue sources of relaxin vary among different mammalian species. In gen­
eral, relaxin is produced in female reproductive tract and the highest levels are ob­
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tained during pregnancy. In pigs, relaxin is produced from the corpora lutea during 
pregnancy and after hysterectomy; small amounts of relaxin can be detected during 
the estrous cycle (Anderson et al., 1973; Sherwood and Rutherford, 1981). The ovary 
is the primary source of relaxin in the species where this organ is needed for normal 
pregnancy such as the rat, mouse, and cow (Schwabe et al., 1978; Anderson et al., 
1982; Anderson, 1987). On the other hand, the ovary produces little, if any, relaxin 
in the species such as sheep where the ovary is not required to maintain pregnancy 
(Larkin et al., 1983). It is also documented that relaxin-like immunoactivity was de­
tected in human seminal plasma (Essig et al., 1982), and boar seminal plasma (Juang 
et al., 1990). 
The corpora lutea of the pig have an inherent capacity to synthesize both relaxin 
and progesterone. Estrogen promotes luteal relaxin synthesis when rats are hysterec­
tomized during the second half of pregnancy. Following its synthesis, relaxin is stored 
in dense, membrane-limited cytoplasmic granules within the source tissue in several 
species including pigs (Belt et al., 1971; Kendall et al., 1978; Fields and Fields, 1985; 
Anderson, 1987). 
Porcine Corpora Lutea 
The corpus luteum is an ephemeral structure and is a pituitary-dependent en­
docrine gland. Its lifespan is self-limiting and species-specific (Anderson, 1962). In 
mammals, the lifespan of corpora lutea varies with species, from the shortest (4-5 
days) in the non-pregnant rat to the longest (10 months) in the roe deer (Rothschild, 
1981). For a given species, luteal lifespan differs greatly for different physiological 
states. For example, the lifespan of porcine corpora lutea of the estrous cycle is about 
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17 days, but it is as long as about 110 days during pregnancy, and even longer after 
hysterectomy (Anderson et al., 1983). 
The corpus luteum is formed through a process called luteinization of the cells 
lining the cavity of the follicle after ovulation and consists of cells originated from the 
granulosa layer of the follicle with some cells of thecal origin (Corner, 1919; Cava-
zos et al., 1969). Accordingly, in mature corpora lutea there are two distinguished 
subpopulations of luteal cells: large and small luteal cells (Lemon and Loir, 1977; 
Huang et al., 1991). The main products of the porcine corpora lutea are proges­
terone and relaxin (Anderson et al., 1970; Belt et al., 1970, 1971). Small amounts of 
prostaglandin F and E (Patek and Watson, 1976, 1983; Guthrie et al., 1978a, 1978b), 
and estradiol-17/3 (Lemon and Loir, 1977; Lemon and Mauleon, 1982) also have been 
identified. 
The corpora lutea increase in diameter from 4-6 mm to 8-9 mm during the first 
week of pregnancy, but exceed 10 mm in diameter in late pregnancy (Anderson and 
Melampy, 1967). On day 14 of pregnancy, the corpora lutea reach a peak mean weight 
of greater than 450 milligrams (Masuda et al., 1967). The corpora lutea of gilts hys­
terectomized during the luteal phase (6-8 days) of the estrous cycle are maintained up 
to day 128 (Anderson et al., 1973) or 152 days (Anderson et al., 1983). The corpora 
lutea regress rapidly at the end of the estrous cycle or after parturition, but regress 
slowly on days 114 post-estrus in the hysterectomized pigs. The regression of corpora 
lutea is caused by a process called luteolysis which has two phases: (1) functional 
luteolysis and (2) structural luteolysis. The functional luteolysis precedes structural 
luteolysis and is characterized by a fall in progesterone production and an increase 
in output of 20-a-hydroxyprogesterone, as well as a loss in luteinizing hormone (LH) 
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receptors of luteal cells (Aakvaag and Torjesen, 1981). Structural luteolysis includes 
(1) a decrease in luteal weight or size; (2) transformational changes in luteal cellular 
ultrastructure; and (3) gradual disappearance of organelles (Corteel, 1975). At the 
beginning of luteolysis, the blood flow through corpora lutea significantly decreases 
(Rathmacker and Anderson, 1968; Ford et al., 1979, 1982; Magness et al., 1983). 
During structural regression, there is an increase in cellular lipid droplets, cytoplas­
mic disorganization, vacuolation of agranular endoplasmic reticulum, an increase in 
number of lysosomes, and an invasion of connective tissue (Cavazos et al., 1969; Belt 
et al., 1970, 1971). Regressive changes also include thickening of the walls of the 
arterioles supplying the luteal cells. As the luteal degeneration progresses, the whole 
organ decreases in size and becomes pale or beige because of the depleted blood sup­
ply. It is worthy to note that there are many similarities between luteal regression 
and somatic tissue senescence (Sawada and Carlson, 1985). 
Hormonal Regulation of Relaxin Production and Secretion 
Relaxin is produced as a secretory polypeptide and packaged in small cytoplasmic 
granules found in the luteal cell. Two lines of evidence support this view: first, 
the accumulation and dissappearance of the cytoplasmic granules during pregnancy 
coincide with the rise and fall of relaxin bioactivity (Belt et al., 1971; Anderson 
et al., 1973); second, the cytoplasmic granules were proved to contain relaxin by 
the methods of immunohistochemistry and electron microscopy immunoperoxidase 
(Kendall et al., 1978, Larkin et al., 1983; Fields and Fields, 1985; Anderson, 1987). 
Throughout the estrous cycle, the levels of relaxin bioactivity are low in extracts 
of ovaries (Hisaw and Zarrow, 1948; Anderson et al., 1973) or in the blood circulation. 
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and they are maximal during the luteal phase (Sherwood and Rutherford, 1981; Fields 
and Fields, 1985). These findings are supported by the following in vitro studies. 
Relaxin was reported to be released from cultured porcine granulosa cells (Loeken 
et al., 1983), thecal cells (Evans et al., 1983), Graafian follicles (Bryant-Greenwood 
et al., 1980; Mastsumoto and Chamley, 1980), and luteal cells (Majumdar and Das, 
1982) from cyclic pigs. 
Levels of relaxin in peripheral blood circulation soon after mating are low (less 
than 2 ng/ml) until about day 100 and then increase gradually to about 10 ng/ml 3 
days before parturition (Belt et al., 1971; Sherwood et al., 1975a; 1975b; Anderson et 
al., 1983). About 2 days preceding parturition, relaxin release reaches maximal levels 
in the peripheral plasma that range from 50 to 250 ng/ml (Sherwood et al., 1975a, 
1976, 1979, 1981; Kendall et al., 1982; Felder et al., 1986; Li et al., 1989). The final 
peak release, or so called antepartum relaxin surge, was observed about 24 to 14 hr 
before parturition. Relaxin levels then decline at birth and remain low throughout 
lactation (Belt et al., 1971; Afele et al., 1979; Sherwood et al., 1981; Felder et al., 
1986). This antepartum relaxin surge accompanies or precedes the onset of delivery; 
with few exceptions, any factor or means of affecting onset of parturition will delay or 
accelerate this antepartum relaxin surge. However, the mechanism(s) whereby this 
relaxin surge occurs remains largely unknown. 
The simultaneous surge in blood relaxin levels might be associated with luteal 
regression (Belt et al., 1971; Sherwood et al., 1979, 1981). Parturition is always pre­
ceded by luteolysis in this species. The fetal pituitary gland and maternal placental 
system are involved in the initiation of parturition in the pig. Destruction of the fetal 
pituitary or fetal decapitation in utero delays parturition, and is known to do so by 
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blocking the rapid luteolysis which normally occurs from days 113 to 115 (Coggins 
and First, 1977). Administration of prostaglandin F2a: (PGF2Q:) to pigs during late 
pregnancy induces an 8-fold increase in relaxin levels in peripheral blood within 30 
min and parturition occurs within 30 hr after PGF2Q: treatment (Sherwood et al., 
1976). Infusion with a dose of 5 mg PGFga on day 110 of pregnancy causes a relaxin 
surge within 1 hr of infusion. Furthermore, daily injections of a PGF2Û! synthesis 
inhibitor, indomethacin, from days 109 to 116 of gestation, delay the relaxin surge 
and parturition for 2 days after the termination of indomethacin injection (Sherwood 
et al., 1979). The evidence from in vitro studies showed that PGF20: can accelerate 
or stimulate relaxin release by porcine luteal cells taken from early or late pregnant 
pigs as detected by reverse hemolytic plaque assay (Taylor and Clark, 1987; Taylor et 
al., 1987). Thus, these findings clearly show that PGF2a, which is luteolytic in the 
pig (Buhr et al., 1986), is one of the factors which can alter the timing and amplitude 
of antepartum relaxin surge. 
Recently, some important progress has been made to reveal the mechanism of 
the antepartum relaxin surge in blood concentration in pigs. Luteinizing hormone 
(LH) and follicle stimulating hormone (FSH) are not responsible for the surge release 
of relaxin during the periparturient period. First, LH and/or FSH blood levels are 
not significantly increased during this period; secondly, exogenous porcine LH (pLH) 
can increase peak release of relaxin during late pregnancy, but the precisely timed 
peak release of relaxin still occurs on day 113 regardless of whether the pregnancy is 
maintained to day 121 (Felder et al., 1988). 
Hysterectomy of the pig in early luteal phase can induce persistent pseudopreg-
nancy, and the corpora lutea (CL) will be sustained beyond 150 days (Anderson et 
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al., 1969). These CL secrete peak quantities of relaxin on about day 114, the same 
time that this occurs in pregnant pigs (Anderson et al., 1983). The profile of relaxin 
concentration in peripheral blood in these hysterectomized pigs is similar to that 
found throughout pregnancy. The maximal populations of electron-dense cytoplas­
mic granules are present on day 100 and decrease about half by day 112 in CL, while 
relaxin blood levels increase. The increase in peripheral blood levels of estrone and 
17/3-estradiol during late pregnancy is unrelated to relaxin secretion (Anderson et 
al., 1983). The estrogen levels are low in the hysterectomized pig throughout days 
6 to 114 and exogenous estrogen actually decreases progesterone secretion from days 
45 to 114 by aging CL in hysterectomized pigs (Musah et al., 1984). Progesterone 
secretion in hysterectomized pigs is greater than that during pregnancy. An abrupt 
decrease by half in progesterone secretion is seen on day 114 and this low level is 
maintained until day 150 post-estrus. This abrupt decrease in progesterone levels in 
these hysterectomized pigs coincides, at least in part, with that observed previously 
at parturition (Adair et al., 1989; Anderson et al., 1983; Musah et al., 1984). 
By using frequent sequential bleeding of pregnant and hysterectomized pigs from 
days 90 to 120 after mating or post-estrus, Felder et al. (1986)showed that a precisely 
timed peak release of relaxin and a coincident decrease in progesterone secretion occur 
in hysterectomized pigs at the same time as seen in pregnant pigs which show an 
antepartum surge of relaxin at day 114 of pregnancy or 24 hr before delivery (Belt et 
al., 1971; Sherwood et al., 1975a, 1975b, 1978, 1979; Felder et al., 1986, 1988). The 
rapid shifts in relaxin and progesterone secretion in these hysterectomized pigs occur 
in the complete absence of structural luteal regression, but with a marked change 
in functional hormone secretion. These CL not only remain large, but also retain 
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some hormone secretory capacity from days 124 to 136 (Adair et al., 1989; Anderson 
et al., 1983; Musah et al., 1984). These findings were interpreted to indicate that 
abrupt shifts in relaxin and progesterone secretion on days 112 and 113 in both 
hysterectomized and pregnant pigs may be due to signals coming from within the 
ovary or from the central nervous system and pituitary gland. 
Administration of LH and prolactin to hysterectomized pigs from days 100 to 
120 enhanced and prolonged the surge release of relaxin and maintained progesterone 
secretion by aging CL. LH stimulated an earher, prolonged peak release of relaxin 
and prolactin induced an earlier relaxin release, prolonged and elevated progesterone 
secretion by original aging CL for at least 10 days (Felder et al., 1988). 
After hypophysectomy or hypophyseal stalk transection of hysterectomized pigs 
at day 110 post-estrus, the amplitude and timing of relaxin surge still occurred about 
day 113. Prolactin administration to these hypophysectomized hysterectomized pigs 
had no effect on the timing of the surge release of relaxin, but maintained progesterone 
secretion to levels of the sham-operated hysterectomized gilts, while hypophysectomized-
hysterectomized gilts receiving saline showed an abrupt decrease in progesterone se­
cretion (Li et al., 1989). Thus, the pituitary gland and possibly, the hypothalamus 
play no direct role in controlling the timing of the surge release of relaxin from the 
aging CL at about 113 days post-estrus in hysterectomized pigs. Instead, the aging 
CL may be preprogramed to express their inherent lifespan of about 114 days de­
fined through evolutionary development of the species. The surge release of relaxin 
is an indicator of the end of luteal lifespan, and the abrupt decrease in progesterone 
secretion is a signal of functional luteolysis. 
RU 486 (mifepristone), is a synthetic antiprogesterone (Baulieu, 1989). Oral 
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administration of RU 486 to pregnant and hysterectomized pigs beginning on days 
111 to 115 at dosages of 2 or 4 mg/kg body weight, delayed the time of the relaxin 
peak from days 113 to 116 (Li et al., 1990a). However, the amplitude of the relaxin 
peak remained similar. In pregnant gilts, earlier parturition was induced at day 112 
when the same RU 486 treatment began at day 111; the timing of relaxin peaks was 
advanced accordingly; the amplitude of the relaxin peak was much greater in RU 486-
treated gilts than that in animals treated with saline. The mechanism underlying 
these abrupt changes seems very complicated. In hysterectomized pigs, RU 486 
may act through the hypothalamic-pituitary axis, the two major target organs for 
progesterone action, inducing a luteotropic signal transmitted to the ovaries. This-
may be the case. The elevated prolactin levels and sustained progesterone secretion 
after RU 486 treatment may support this explanation. In pregnant animals, RU 486 
treatment may induce luteotropic effects from the hypothalamic-pituitary axis as well 
as luteolytic actions primarily from the gravid uterus and fetus(es). It may be that 
the luteotropic actions of RU 486 were superseded by luteolytic actions resulting in 
earlier parturition (Li et al., 1990b). 
As described above, during the period from days 110 to 116 post-estrus in preg­
nant and hysterectomized pigs, the luteal hormone secretion is shifted dramatically. 
But there is little information about what happens in luteal cells concerning the hor­
monal responsiveness and hormonal secretory capacity. Huang et al. (1991) reported 
that progesterone secretory capacity decreased in cultured luteal cells from pregnant 
as well as from hysterectomized pigs at days 113 and 116 compared with those from 
day 110 in the same group. The responsiveness of these luteal cells to treatments of 
LH, prolactin and prostaglandins was lost in terms of progesterone secretion by cells 
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from days 113 and 116 in both groups of animals. In contrast, the responsiveness, 
with regard to relaxin secretion, increased at days 113 and 116 compared with those 
from day 110. 
Relaxin Actions 
Relaxin is currently known as a pregnancy-associated polypeptide hormone. Its 
primary target organs for physiological action appear to be components of the repro­
ductive system including the uterus and the cervix. Relaxin promotes the growth of 
the uterus, regulates the contractility of uterine myometrium, and plays a key role in 
the connective tissue remodeling during pregnancy and parturition. To a less extent, 
relaxin also affects the growth and development of the mammary glands (Hurley et 
al., 1991) and has a role in the sperm motility (Juang et al., 1990). The mecha-
nism(s) of relaxin action is still not completely understood. An appropriate model 
is the uterus where inhibition of uterine contraction by relaxin may be mediated by 
a cAMP pathway, but it is not clear how relaxin acts to regulate connective tissue 
remodeling. 
The growth-promoting effect of relaxin has yielded much research with the rat 
and mouse models. A single injection of partially purified relaxin into the ovariec-
tomized estrogen-primed rat caused a significant increase in the wet uterine weight 
(Steinetz et al., 1957). These uterine growth promoting effects of relaxin were con­
firmed and further described by other investigators (Zarrow and Brennan, 1957; Bren-
nan and Zarrow, 1959; Kroc et al., 1959; Brody and Wiqvist, 1961; Wada and Turner, 
1961). Treatment with purified relaxin caused a linear increase in uterine glycogen 
concentration increased linearly with the log of the dose over the range of 3 - 30 fig in 
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estrogen-primed rats (Vasilenko et al., 1980; 1981). The effect of relaxin on the growth 
of the uterine cervix in addition to the uterus was reported by Vasilenko and Mead 
(1987) where relaxin exhibited significant growth-promoting effect on the cervix of 
the ovariectomized-estrogen-primed rat 6 h after a single injection of 30 //g relaxin. 
The cervical wet weight, dry weight, and water content were increased in a dose-
dependent manner. However, the collagen concentration decreased compared with 
the value in the controls. Histological and histochemical analysis of relaxin action on 
the uterine structures revealed that alterations occurred after relaxin treatment in 
the connective tissue framework of both endometrium and myometrium (Vasilenko et 
al., 1986); these changes included collage fibers being loosely arranged, disorganized, 
and widely separated. Relaxin also stimulated significantly greater vascularization 
as evidenced by the size of arteries and veins in the relaxin-treated uteri. An in­
creased blood supply may be considered to be one of the possible mechanisms by 
which relaxin stimulates tissue growth and water imbibition of the uterus. 
Unilaterally ovariectomized gilts injected with 0.5 mg relaxin/6 h from days 8 to 
11 after mating significantly increased uterine wet weight (Galvin et al., 1988), but 
the DNA and protein content were not affected by relaxin treatments. The water 
imbibition was thought to be the contributor to the increased wet weights of the 
uterus. A hypothesis was put forward to test that relaxin action on water imbibi­
tion may be mediated by histamine since this compound has a role in the formation 
of edema in several tissues. The results from the experiments, designed to test the 
above hypothesis, demonstrated that the water imbibition effect of relaxin was not 
mediated by histamine because relaxin stimulated imbibition of water by the uterine 
tissue despite the presence of histamine receptor antagonists (Hall et al., 1989). How­
ever, the uterotropic effects of relaxin in intact, prepubertal gilts were confirmed as 
evidenced by hyperplastic growth of the uterine tissues and concomitantly increased 
content of the uterine protein. 
The growth promoting effects of relaxin on the uterus and cervix are expected 
because throughout pregnancy, the uterus and cervix grow and remodel to accommo­
date the growth of the fetuses, especially in mid- and late-pregnancy. This parallels 
the elevated estrogen blood levels and gradually increased relaxin concentrations 
during mid- and late-pregnancy. Since the relaxin concentrations in peripheral blood 
increased only in late pregnancy and reached peak levels just preceding delivery, the 
major physiological action of relaxin is speculated to be related to the preparation of 
the birth canal. 
The cartilage of the pubic symphysis of mature female guinea pigs consists largely 
of compact collagen fibers which are embedded in an amorphous extracellular ma­
trix. Transformation of this connective tissue of the pubic symphysis occurs during 
the last 4 weeks of the 9-week gestation. The dramatic changes include a marked 
increase in the vascularity, wet weight, and length of the interpubic ligament during 
the last week of pregnancy (Wahl et al., 1977). Physical transformation of this tissue 
during pregnancy is hormonally regulated. Estrogen can induce an increase in inter­
pubic ligament length, proliferation of fibrous connective tissue, and an increase in 
water content (Hisaw and Zarrow, 1950). Relaxin alone has no effect on symphyseal 
connective tissue in this species. However, the transformation of the symphyseal con­
nective tissue was detected within 6 to 8 hr after treatment with relaxin in castrated 
adult guinea pigs pretreated with estrogen for 4 or more days (Zarrow, 1948). The 
extensive dissolution and disorientation of the collagen fibers occur following relaxin 
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administration, and the pubic symphysis became a bloody, spongy, and highly flexi­
ble structure (Chihal and Espey, 1973). The mechanism by which relaxin promotes 
dissolution and disorientation of collagen in the guinea pig pubic symphysis remains 
to be determined. 
In cattle, dilatation of the cervix increases markedly during late pregnancy. Im-
munoreactive relaxin concentrations in peripheral blood of beef and dairy heifers, as 
determined by porcine relaxin radioimmunoassay, are very low during late pregnancy 
(Musah et al., 1987; Bagna et al., 1991) and increase only just before parturition 
(Anderson et al,, 1982). Administration of highly purified porcine relaxin induces an 
increase in both pelvic area and cervical dilatation in beef higher during late preg­
nancy (Perezgrovas and Anderson, 1982; Musah et al., 1986a, 1986b). The pelvic 
area and cervical dilatation increase significantly within 12 hr after intracervical ap­
plication of either 3,000 U relaxin once or twice on days 277 and 278 (Musah et al., 
1986a). Relaxin treatment also induced premature parturition with marked pelvic 
canal expansion and cervical relaxation (Musah et al., 1986b). By measurements of 
the pelvic area, cervical dilatation, and peripheral blood concentrations of proges­
terone and relaxin, Bagna et al. (1991) reported that two i.m. injections at 12-hr 
intervals of relaxin on day 276 or 277 facilitated earlier calving, acutely decreased 
progesterone levels, increased cervical dilatation and pelvic canal expansion, and de­
creased the incidence of dystocia in dairy heifers. 
In the pig, relaxin's action on the cervix has not received adequate attention until 
recently. As early as in the mid-1950s, Zarrow et al. (1956) showed that partially 
purified porcine relaxin increased cervical dilatation in both ovariectomized, estrogen-
primed nonpregnant and pregnant pigs given 3 daily i.m. injections of relaxin for 4 
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days. The dilatation of the cervix was accompanied by an increase in water content 
and depolymerization of cervical glycoprotein. Kertiles and Anderson (1979) reported 
that daily injection of relaxin beginning on day 105 or 107 increased cervical dilatation 
in pigs that were luteectomized on day 110. Eldridge-White et al. (1989) described 
the time course of physical changes in the cervix that occur throughout pregnancy 
in the pig, which were highly correlated temporally with elevated serum levels of 
estrogen and relaxin. The marked increases in weight and extensibility of the cervix 
appear between days 80 and 90 of gestation, and these continue to steadily increase 
until delivery. During this period, estrogen levels in the peripheral blood begin to 
rise but relaxin is still in relative low levels. The authors suggested that the rising 
levels of estrogen may induce an increase in relaxin receptors so that low levels of 
relaxin become effective. 
Mechanism of Relaxin Actions 
The first step of relaxin action is binding to its specific receptor in the target 
cell surface. The specific receptors for relaxin have been partially characterized in 
rat uterine membrane-enriched fractions with a high affinity with a Kd of 10 M 
(Mercado-Simmen et al., 1980). There are two classes of binding sites for relaxin: 
one of high affinity and low capacity, and another of low affinity and high capacity. 
McMurtry et al. (1978, 1980) reported that the binding of ^^^I-iodo-succinylated 
porcine relaxin to homogenates of mouse and guinea pig pubic symphysis, rat and 
mouse uterine tissues was temperature, pH, and time dependent. The binding can 
be displaced by addition of unlabeled relaxin to the incubation medium. 
Estrogen is known to regulate relaxin receptor concentration and expression. Es-
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trogen increased the concentration of myometrial relaxin receptors whereas relaxin 
down-regulated its own receptors in the rat (Bryant-Greenwood et al., 1982), and in 
both cases, the affinity constant was not affected (Mercado-Simmen et al., 1982a, b). 
In cyclic rats, there is no detectable relaxin binding, and the same was observed in 
ovariectomized rats. The administration of estrogen to the cyclic rat or the ovariec-
tomized rat brings about high affinity binding sites to the extent seen in the pregnant 
animals (Mercado-Simmen, 1980). Thus, estrogen may be one of the factors which 
regulates the tissue-specific expression of relaxin and its function in the target tissues. 
Pregnancy in rats lasts about 22 days. The maximal relaxin receptor population 
was seen between days 16-18 of the pregnant rat (Mercado-Simmen et al., 1982a, b), 
while the highest relaxin plasma level appeared at days 19-21 (Sherwood et al., 1980). 
Decreasing relaxin receptor population during this period (days 19-21) indicated that 
relaxin could down regulate its own receptor population without effect on the binding 
affinity (Mercado-Simmen et al., 1982a, b). The timing of relaxin receptor population 
changes seemed to be correlated with physiological functions since the ripening and 
softening of the cervix occurred at days 18-22 of pregnancy in the rat (Downing and 
Sherwood, 1985). 
The inner circular layer of the myometrium appears to be a major site for re­
laxin action since it has a greater density of relaxin receptors compared with the 
outer layer (Weiss et al., 1982). The cervix of estrogen-primed rats exhibits specific 
receptor for relaxin, and the binding sites on the cervix are about the same on the 
uterus. However, the mechanism of hormonal regulation of relaxin receptor popula­
tion may differ (Weiss et al., 1982). Specific binding sites for relaxin are also present 
in the myometrium and cervix of both cyclic and prepubertal PMSG-hCG-treated 
18 
f  
pigs (Mercado-Simmen et al., 1982a, b). 
After relaxin binding to its receptor, the membrane transduction mechanism for 
relaxin action is not clearly resolved. The evidence accumulated thus far favors cyclic 
AMP (cAMP) as a second messenger. The earliest evidence was from the report of 
Braddon (1978) who found that relaxin elevated cAMP in the pubic symphysis of 
the mouse. Later, several groups of investigators reported that relaxin treatment 
can cause an elevated cAMP in the uterus and cervix of rats (Cheah and Sherwood, 
1980; Sanborn et al., 1980a). The increase in cAMP was time- and dose-dependent. 
The maximal increase in cAMP levels occurred within 15 min of co-incubation of 
relaxin with the tissue in the presence of theophylline, an inhibitor of cAMP phos­
phodiesterase. 
Relaxin induced elevated levels of cAMP from rat uterine strip, and this effect 
was not mediated by catecholamine or by prostaglandin (Sanborn et al., 1980b), since 
inhibition of catecholamine or prostaglandin synthesis did not block the stimulatory 
effect on cAMP by relaxin. Furthermore, Kemp (1981) observed that relaxin activates 
the uterine cAMP-dependent protein kinase and the time course of activation was 
similar to that reported by Sanborn et al. (1981). In human endometrial glandular 
epithelial cells, the adenylate cyclase enzyme system responds to relaxin treatment 
to stimulate the accumulation of intracellular cAMP. In the presence of phospho­
diesterase inhibitor, accumulation of cAMP after relaxin treatment was time- and 
dose-dependent, this accumulation was apparent in 5 min, reached a maximum after 
15 min, and remained elevated for 17 hr incubation with the effective doses of relaxin 
ranging from 10-100 ng/ml of incubation medium (Chen et al., 1988). 
Porcine relaxin stimulated a significant increase in tissue content of cAMP in 
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the uterus and cervix from pregnant and term women (Norstrom and Wiqvist, 1985), 
but had no effect on the tissue from nonpregnant women. Human relaxin elevated 
the cyclic AMP content of cultured rat anterior pituitary cells in a dose-dependent 
manner, this response can be aborted by anti-relaxin antibodies or the hormones: 
somatostatin and dopamine, both are capable of decreasing cycUc AMP content in 
pituitary cells (Cronin et al., 1987). Taken together, the current experimental ob­
servations suggest, but do not prove, that the actions of relaxin on the target cells 
may be mediated, at least partially, by an adenylate cyclase-cyclic AMP pathway. 
However, these findings do not exclude other possible mechanisms to mediate actions 
of relaxin. Prostaglandin may be one of these mediators. Pretreatment of mice with 
indomethacin (a prostaglandin synthase inhibitor) prevented the increase in cervical 
dilatation in connection with relaxin administration (Kennedy, 1976). 
The uterus is composed of an outer serous coat (perimetrium), an outer longitu­
dinal and inner circular layers of smooth muscle (myometrium), and an inner mucous 
lining (endometrium). The cervix is the caudal and relatively narrow segment of 
the uterus; its wall is continuous with the rest of the uterus. The smooth muscle 
layers of the uterus fade away in the cervix, especially in the caudal portion. The 
cervical wall is composed mainly of dense collagenic connective tissue, but few elastic 
fibers, except in the wall of its blood vessels. Hydroxyproline is a unique amino acid, 
found only in the collagen and elastic fibers. Thus the content or concentration of 
hydroxyproline can be used as an index of collagen. 
Collagen is a ubiquitous protein and it represents about 82% of the total protein 
in human cervix (Danforth, 1980). The concentrations of collagen in the cervix 
are under hormonal regulation and dependent on the physiological status of the 
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animal. Downing and Sherwood (1986) reported that relaxin treatment promoted an 
increase in collagen solubility, a decrease in collagen concentration, and an increase in 
glycosaminoglycan content in the cervices of steroid-treated pregnant rats. Anabolic 
effects of relaxin on collagen content were also reported. 
Anabolic effects of relaxin on noncollagen protein were also reported such as 
increased incorporation of ^^C-phenylalanine into uterine protein in ovariectomized, 
estrogen-primed, immature rats (Frieden and Adams, 1985) and an increase in non-
collagen protein synthesis by mammary fibroblasts (Sheffield and Anderson, 1984). 
One of the factors responsible for cervical effacement and dilatation is collagen 
destruction which can be attributed to activity of collagenase. Relaxin was reported 
to activate the collagenolytic system in the mouse symphysis which led to a decrease 
in total collagen content. The effect of relaxin could be suppressed by treatment with 
relaxin-specific antisera (Weiss et al., 1979). Relaxin has been shown to affect the 
activities of collagenase, proteoglycanase, and /3-glucouronidase in the rat uterus and 
cervix in different reproductive states (Too et al., 1986). In the rat granulosa cells, 
relaxin increases total collagenase and proteoglycanase activities (Too et al., 1984). 
Dilatation of the human and guinea pig uterine cervices at birth involves morpho­
logical changes and collagenolysis which were preceded or accompanied by a marked 
increase in collagenase (Rajabi et al., 1985). High circulating concentrations of col­
lagenase have been observed in women during normal labor. Rapid collagen degra­
dation is one of the events required in the remodeling of connective tissue such as 
postpartum uterine involution, bone resorption, wound healing, ovulation and em-
bryogenesis and in pathological processes such as osteoarthritis, rheumatoid arthri­
tis, peri dont al disease and tumor invasion (Stricklin and Hibbs, 1988). Histologi-
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cal changes induced by relaxin treatment in the rabbit cervix were similar to those 
observed during normal labor — these histological changes were attributed to the 
activities of collagenolytic enzymes (MacLennan et al., 1985). 
Explanation of Dissertation Format 
This dissertation has been written in accordance with the specifications for the 
alternative dissertation format described in Iowa State University Graduate College 
Thesis Manual (1990). There are four sections in this dissertation which represent 
four papers resulting from a series of research activities during the period from 1988 
to 1991. The first section was completed in 1990, the results were presented at 
the 23rd Annual Meeting of the Society for the Study of Reproduction, and was 
submitted for review by the Journal of Reproduction and Fertility. The second was 
completed in 1991, the results were presented at the 81st Annual Meeting of the 
American Society of Animal Science and at the 5th Life Sciences Symposium of Iowa 
State University. The third and fourth sections were completed in 1991, the results 
will be presented at the 83rd Annual Meeting of the American Society of Animal 
Science. All sections have been written in the style of Biology of Reproduction (1990) 
in accordance with the requirements of the thesis office. Besides these four sections, 
there are a general introduction to address the purpose of these experiments, a review 
of literature to summarize previous work on this subject, a summary and discussion 
from each of these four experiments, and a section of supplemental references for the 
general introduction, summary and discussion. Supplemental materials are presented 
in the Appendix and Tables. 
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SECTION I. SYNERGISTIC EFFECTS OF INSULIN-LIKE GROWTH 
FACTOR-I AND GONADOTROPINS ON RELAXIN AND 
PROGESTERONE SECRETION BY AGING PORCINE CORPORA 
LUTEA 
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ABSTRACT 
Insulin-like growth factor-I (IGF-I) is involved in paracrine and/or autocrine 
regulation of gonadal steroidogenesis and peptide hormone biosynthesis. The present 
study was designed to determine a possible role of IGF-I alone, or an interaction of 
IGF-I in augmenting the actions of luteinizing hormone (LH), and prolactin (PRL) in 
controlling relaxin and progesterone secretion from aging corpora lutea of hysterec­
tomized gilts at Days 110, 113, and 116. Luteal tissue slices were incubated for 8 h 
with addition of IGF-I (0, 50, 300 ng/ml), LH (0, 100, 1000 ng/ml), and PRL (0, 100, 
1000 ng/ml). alone or in combination. Progesterone and relaxin concentrations were 
determined by radioimmunoassay of spent medium and of homogenates from luteal 
tissue slices before and after incubation. Porcine luteal tissue from Day 110 had a 
net output (i.e., ng/mg luteal tissue) of 25 progesterone and 26 relaxin in the control 
and of 65 progesterone and 2125 relaxin in the combined IGF-I-LH-PRL treatment, 
respectively. IGF-I, LH, and PRL alone or in combination increased (P<0.01) pro­
gesterone production by luteal tissue from Day 110, but they were ineffective at Days 
113 and 116. In contrast, the same hormone treatments increased relaxin production 
by luteal tissue from Days 110 and 113 compared with those tissues from Day 116. 
In conclusion, IGF-I augments the ability of PRL and LH to increase progesterone 
and relaxin production by aging corpora lutea; however, a decreased response in pro­
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gesterone secretion and increased response in relaxin secretion at Day 113 indicate 
that different mechanisms control progesterone and relaxin secretion in the pig. 
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INTRODUCTION 
Relaxin and progesterone are produced by pig corpora lutea during pregnancy 
and after hysterectomy (Belt et al., 1970, 1971; Anderson et al., 1973, 1983). The 
corpora lutea from estrous cycles of about 21 days secrete progesterone and small 
amounts of relaxin (Masuda et al., 1967; Anderson et al., 1973; Sherwood and Ruther­
ford, 1981). During a normal pregnancy of 114 days, circulating progesterone concen­
trations peak by Day 8 and remain elevated until they decrease just before parturition. 
Relaxin accumulates in luteal tissue and increases gradually during pregnancy, and 
it is released into the blood in peak quantities just before parturition (Belt et al., 
1971; Sherwood et al., 1981; Felder et al., 1986; Li et al., 1989). After hysterec­
tomy of unmated gilts, the corpora lutea are maintained beyond the duration of the 
normal pregnancy; these aging corpora lutea continue to secrete relaxin and proges­
terone. The profiles of decreased progesterone secretion and simultaneous increase 
in relaxin secretion from these aging corpora lutea at Day 113 were similar to those 
on the same day just preceding normal parturition (Felder et al., 1986; Li et al., 
1989; Adair et al., 1989). Relaxin and progesterone secretion from aging corpora 
lutea of hysterectomized gilts are increased by prolactin (PRL) and luteinizing hor­
mone (LH) in vitro (Huang et al., 1991) and in vivo (Felder et al., 1988; Li et al., 
1989). However, whether the increased relaxin secretion is caused by relaxin release 
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from a preformed hormone pool or requires biosynthesis of the hormone is unknown. 
Furthermore, the interaction of PRL with LH may play a role in steroidogenesis be­
cause physiological concentrations of LH increase PRL receptor numbers (Chen et 
al., 1981), and PRL can increase LH receptors (Richards, 1978). Insulin-like growth 
factor-I (IGF-I) is involved in gonadal steroidogenesis and peptide biosynthesis in an 
autocrine or paracrine manner (Adashi et al., 1985a; Kasson and Hsueh, 1987; Caubo 
et al., 1989). 
This study was designed to determine the roles of IGF-I, LH, and PRL alone 
or in combination on the regulation of relaxin and progesterone secretion from aging 
corpora lutea of hysterectomized gilts during a period equivalent to late pregnancy 
and normal parturition in this species. 
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MATERIALS AND METHODS 
Chemicals 
The following reagents were obtained from Sigma Chemical Co., St Louis, MO: 
Dulbecco's Modified Eagle's Medium (DMEM, D5523); bovine transferrin (T5761); 
low-density lipoprotein (LDL, from human plasma L2139); and porcine insulin (13505). 
Insulin-like growth factor-I (IGF-I, H541) was obtained from IMCERA Bioproducts 
Inc., Terre Haute, IN. Porcine prolactin (USDA-pPRL-B-1) and porcine luteinizing 
hormone (USDA-pLH-B-1) were generously provided by Dr. D. J. Bolt, Reproduc­
tion Laboratory, USDA, BeltsviUe, MD, and Dr. S. Raiti, National Hormone and 
Pituitary Program, NIH, Baltimore, MD. 
Animals 
All ovaries were obtained by ovariectomy of purebred Yorkshire gilts previously 
hysterectomized at Day 8 (estrus = Day 0), at Days 110 (N = 5), 113 (N = 5), and 
116 (N = 5) after estrus. Each corpus luteum was marked with a loop of black silk 
suture at hysterectomy for later identification. Corpora lutea from both ovaries of 
each of the 15 pigs were used for one incubation and for electron microscopy. 
Tissue incubation 
The corpora lutea were dissected from the ovarian stroma and trimmed immedi­
ately. Luteal slices averaging 0.4 mm thickness (each weighing about 50-60 mg) were 
cut with a microtome. Three luteal slices from each pig were saved to determine 
hormone storage at time zero. One tissue slice per well in a 24-well, flat-bottom 
culture plate with cover lid (Falcon 3847, Becton Dickinson Labware, Lincoln Park, 
NJ) was incubated for 8 h in a Dubnoff Metabolic Shaking Incubator at 37°C, 5% 
COg, 95% O2 with an oscillating speed of 60 cycles/min. Hormone treatments (each 
in triplicate) added to the incubation media were 0, 50, and 300 ng/ml IGF-I; 0, 100, 
and 1000 ng/ml LH; and 0, 100, and 1000 ng/ml PRL. These hormones and dosages 
are abbreviated in the figures and text as IGF50, IGF300, LHIOO, LHIOOO, PRLIOO, 
and PRLIOOO. The greatest concentration of each hormone was used in two- and 
three-factorial combinations to test hormonal interactions. The incubation medium 
(1 ml/well) was DMEM supplemented with LDL (10 fig/ml), insulin (5 //g/ml), and 
transferrin (5 /tg/ml). Appropriate controls were included in luteal tissue incubations 
for each series of hormone treatments. The spent medium from each incubation well 
was radioimmunoassayed for relaxin and progesterone. Each luteal tissue slice was 
blotted, weighed, and homogenized for the hormone assays. The incubation proce­
dure for the hormone treatments described here was carried out independently for 
each of the 15 animals in the study. 
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Electron microscopy 
Fixation and dehydration of the luteal tissue were performed at 2°C. The tissue 
was cut into cubes < 1 mm on a side and fixed 3 h in 2.5% glutaraldehyde in Millonig's 
phosphate buffer, pH 7.25. Silver sections (70-80 nm) were cut on a glass knife with a 
LKB Ultrotome III microtome (LKB Instruments, Rockville, MD). The thin sections 
were double-stained, first with 2% uranyl acetate in methanol and then with lead 
citrate, and examined in a JEOL-IOOCXII electron microscope (Adair et al., 1989). 
From each of the 15 gilts in this study, 21 blocks of luteal tissue were fixed of which 
two blocks were randomly selected for electron microscopy. If the fine structure of 
those two samples differed, another two blocks were randomly selected for electron 
microscopy to ensure samples representative of the luteal tissue. Six micrographs 
were prepared from each block for selection of photomicrographs representative of 
luteal cells from Days 110, 113, and 116. 
Radioimmunoassay of progesterone 
The procedures for radioimmunoassay of progesterone in the incubation medium 
and luteal tissue homogenates were the same as described previously (Felder et al., 
1986). Briefly, progesterone concentrations in the incubation medium were assayed 
in duplicate 50 /il aliquots of a 1:50 dilution. Assay sensitivity for the incubation 
medium was 50 pg per tube (range, 50-10,000 pg). To determine the precision and 
accuracy of this assay, 0, 50, 100, 250, 500, 1000, 2500, 5000 and 10,000 pg pro­
gesterone were added in quadruplicate aliquots of 50 /il incubation medium. These 
standard samples were assayed, blank values were subtracted, and the concentrations 
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of progesterone averaged (± s.e.) 0, 46 ± 5, 100 ± 8, 226 ± 15, 547 ± 15, 1027 ± 44, 
2835 ± 96, 5027 ± 111, and 9179 ± 118 pg/50 /il, respectively. Replicate samples 
were included in each assay for determination of intra- and inter-assay variances which 
were 7.5% (N = 9) and 9.6% (N = 9), respectively. Nonspecific binding was 3.7% 
and the maximal antibody binding was 34.3%. Progesterone contents in luteal tissue 
slices (i.e., 50-60 mg) were quantified in duplicate 50 fd samples of a 1:100 dilution 
of the homogenate of fresh tissue (i.e., equivalent to 0.5 mg/ml 0.01 M PBS). The 
assay sensitivity was 50 pg per tube (range, 50-10,000 pg). The intra- and inter-assay 
variances were 7.8% and 11.5%, respectively. Nonspecific binding was 2.8% and the 
maximal antibody binding was 34.8%. 
Radioimmunoassay of relaxin 
The procedures for radioimmunoassay of relaxin in the incubation medium and 
luteal tissue homogenates were the same as described previously (Felder et al., 1986). 
Briefly relaxin concentrations in the incubation medium were assayed in duplicate 
50 /il aliquots of a 1:2000 dilution. Assay sensitivity for the incubation medium was 
50 pg per tube (range, 50-5000 pg). To determine the precision and accuracy of this 
assay, 0, 50, 100, 1000, 2000, 4000, and 5000 pg purified porcine relaxin were added 
to quadruplicate aliquots of 50 /il incubation medium. These standard samples were 
assayed, blank values were subtracted, and the concentrations of relaxin averaged (± 
s.e.) 0, 54 ± 13, 95 ± 13, 1228 ± 44, 2261 ± 85, 3499 ± 74, and 5003 ± 70 pg/50 /il, 
respectively. Replicate samples were included in each assay for determination of intra-
and inter-assay variances which were 6.7% (N = 9) and 9.0% (N = 9), respectively. 
Nonspecific binding was 3.4% and maximal antibody binding was 34.2%. Relaxin 
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contents in luteal tissue slices (i.e., 50-60 mg) were quantified in duplicate 50 /il 
samples of a 1:4000 dilution of the homogenate of fresh tissue (i.e., equivalent to 12.5 
^g/ml of 0.01 M PBS). The assay sensitivity was 50 pg (range, 50-5000 pg). The 
intra- and inter-assay variances were 6.3% (N = 9 and 12.8% (N = 9), respectively. 
Nonspecific binding was 2.8 and the maximal antibody binding was 34.3%. 
Protein determination 
The protein content in the extract of each luteal slice was determined spectropho-
tometrically by using an acidic solution of Coomassie Brilliant Blue G-250 (500-600, 
Bio-Rad Protein Assay, Bio-Rad Chemical Division, Richmond, CA) and measuring 
the absorbance at 595 nM (Bradford, 1976). The assay standard was crystalline BSA 
(Armour Pharmaceutical Co., Chicago, IL). 
Statistical analysis 
Data were analyzed by the least square analysis of variance using the General 
Linear Models procedure of the Statistical Analysis System (SAS, 1985). The exper­
imental units are tissue slices at culture wells. To test the effects of treatments, data 
were pooled within a day and the Least Significant Difference was applied using Day 
X Treatment as error term to compare treatment means with the control value within 
that day (Snedecor and Cochran, 1989). 
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RESULTS 
IGF-I stimulated progesterone production and secretion by incubated tissue 
slices from aging corpora lutea of the pig (Table 1). Thus, IGF-I was used for two-
and three-factorial combinations with gonadotropins. All hormone treatments alone 
or in combination stimulated total progesterone concentration at Day 110, but they 
were ineffective at Days 113 and 116. Furthermore, PRL, LH or PRL plus LH in 
combination with IGF-I produced a further increase in progesterone concentration 
compared with the effects of IGF-I alone. 
Cumulative relaxin concentration in the medium and luteal tissue after 8 h incu­
bation is presented in Table 1. IGF-I or LH alone was ineffective in increasing relaxin 
concentrations at Day 110, whereas PRL alone stimulated relaxin production at this 
time. When IGF-I was combined with PRL or LH, relaxin production was further in­
creased, and the combination of IGF-I with PRL plus LH yielded the greatest relaxin 
concentration during this brief period of incubation at Day 110. By Days 113 and 
116, relaxin concentration in the controls decreased compared with Day 110 luteal 
tissue incubations. A similar pattern of the stimulatory effects of IGF-I combined 
with gonadotropins was seen at Day 113 when compared with Day 110. By Day 
116, relaxin concentration in the controls had decreased, but IGF-I treatments with 
PRL, LH or PRL plus LH significantly increased relaxin concentrations (P < 0.05). 
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Table 1: Mean progesterone and relaxin concentrations in incubation medium and 
tissue (ng/ mg tissue during 8 h incubation) fron hysterectomized pigs at 
Days 110. 113, and 116 (hysterectomy performed at Day 8. estrus = Day 
0)' 
Progesterone Relaxin 
No. of 
animals 
within Day Day Day Day Day Day 
day 110 113 116 110 113 116 
Control 5 179 161 166 3501 3144 3087 
IGF-I 10 193" 160 168 3770 3437 3314 
LH 10 193" 172 174 3791 3555" 3324 
PRL 10 204' 162 169 3883" 3571" 3310 
PRL + LH 5 205' 179' 166 3816 3486" 3622' 
IGF-I + PRL 5 205'° 163 164 4151'° 3784''° 3601' 
IGF-I + LH 5 222'"'" 170 174 4275'" 4501'"'" 3401" 
IGF-I + PRL + LH 5 2^gb,d.e 164 166 5600''""'' 3957'" 3521" 
Pooled s.e.m. 3 2 1 140 48 34 
Values are means and pooled s.e.m. within day. Doses of the hormones added were control 0, 
IGF-I 300 ng/ml, LH 1000 ng/ml, PRL 1000 ng/ml. 
Means within columns with superscript letters are different from the control values: 
a {P < 0.05), b {P < 0.01). 
Means within columns with superscript letters are different from the IGF-I values: 
c {P < 0.05), d (P < O.OI). 
Means within columns with superscript letters are different from the IGF-I + PRL values: 
e {P < 0.05). 
Means within columns with superscript letters are different from the IGF-I + LH values: 
f (P < 0.05). 
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The profiles of net progesterone and relaxin production are presented in Figure 
lA and IB. Net hormone production was defined as the difference in hormone con­
centration in luteal tissue and medium after 8 h compared with 0 h incubation. This 
net hormone production resulted from the biosynthesis of progesterone and relaxin 
by luteal tissue in response to different hormone challenges during 8 h incubation. 
All hormone treatments at Day 110 increased net progesterone biosynthesis (Figure 
lA). At Day 113, only LH alone or combined with PRL significantly stimulated pro­
gesterone biosynthesis. By Day 116, all hormone treatments were ineffective, but net 
progesterone production remained unchanged from that of the controls at Days 110 
and 113 (Figure lA). Over all treatments, net progesterone concentration at Day 110 
averaged 48 ± 4 ng/mg luteal tissue, which was significantly greater (P<0.05) than 
36 ± 3 ng/mg at Day 113, and 34 ± 1 ng/mg at Day 116. 
At Day 110, PRL alone and combined with LH or IGF-I stimulated relaxin 
biosynthesis (Figure IB). The greatest increase in relaxin biosynthesis resulted when 
IGF-I was combined with PRL and LH at this time. A similar response to go­
nadotropin treatments was seen at Day 113, but the greatest net production of relaxin 
occurred when IGF-I was combined with LH or PRL. Only PRL alone or combined 
with LH or IGF-I increased (P<0.05) relaxin biosynthesis at Day 116. The negative 
value for the controls at Day 116 may reflect relaxin degradation with little or no 
hormone biosynthesis during 8 h incubation. Over all treatments, relaxin concen­
tration at Day 110 was 547 ± 165 ng/mg luteal tissue, which was similar to 496 ± 
110 ng/mg at Day 113 and greater (P<0.05) than 200 ± 48 ng/mg seen at Day 116. 
There was a high correlation (r = 0.93 for progesterone, 0.95 for relaxin, P<0.01) 
between hormone concentration expressed as ng/mg luteal tissue and 
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Figure 1; Net progesterone (A) and net relaxin (B) released during 8 h incubation of 
aging luteal tissue from hysterectomized pigs at Days 110. 113. and 116 
(hysterectomy performed at Day 8. estrus = 0). Treatments are IGF-I 
0, 50, 300 ng/ml; LH 0, 100. 1000 ng/ml; PRL 0, 100, 1000 ng/ml; the 
greatest dosage of each tested hormone was used in two- or three-factor 
combinations. Values are means ± s.e.m. Comparison with control (a; P 
< 0.05; b: F < 0.01) was made within a day (N = 5 animals, treatment 
replication = 3 within animal and day). 
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ng/mg protein; thus, the results of progesterone and relaxin production were ex­
pressed as ng/mg luteal tissue. 
Luteal tissue from these hysterectomized gilts at Day 110 contained maximal 
numbers of electron-dense granules in the cytoplasm, which were distributed in clus­
ters among abundant large mitochondria (Figure 2A). Empty vesicles were inter­
spersed among the Golgi complexes. A granular or smooth endoplasmic reticulum 
(SER) and granular or rough endoplasmic reticulum were present at Day 110 as well 
as Days 113 and 116, but SER was far more abundant. By Day 113, the population of 
cytoplasmic granules was slightly less than seen at Day 110, and more empty vesicles 
appeared (Figure 2B). Fewer cytoplasmic granules and more small, empty vesicles 
were seen by Day 116 (Figure 2C). An invasion of collagen between the luteal cells 
was evident at this time. Mitochondria were enlarged and had fewer fenestrated 
lamelliform cristae. Large lipid bodies and multilamellar bodies were also frequently 
seen in Day 116 samples (data not shown). 
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Figure 2: A) luteal tissues removed at Day 110 of hysterectomized pigs contain 
abundant electron-dense cytoplasmic granules (GR). Some vesicles (V) 
seemed empty. Mitochondria (M) of various sizes are prominent. B) 
luteal tissues removed at Day 113 of hysterectomy also contain consider­
able number of cytoplasmic granules (GR); more empty vesicles (V) were 
seen. C) luteal tissues removed at Day 116 of hysterectomy contain fewer 
cytoplasmic granules (GR). An invasion of collagen between the luteal 
cells was seen, and there are enlarged mitochondria (M) that had fewer 
fenestrated lamelliform cristae. Bar = 1 /im, magnification X 16,500. 
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DISCUSSION 
The results from this study show that IGF-I augments relaxin production and 
release by aging luteal tissue removed from hysterectomized gilts at Days 110 and 
113 after estrus when co-incubated for 8 h with LH and PRL. By Day 116, how­
ever, relaxin production in response to these hormones was marginal. Progesterone 
production and release was increased by IGF-I alone and further increased when co-
incubated with PRL and(or) LH at Day 110, but not at Days 113 and 116. Thus 
these trophic hormone responses of aging luteal tissues to IGF-I and gonadotrophins 
are day-dependent and with a distinct difference between relaxin and progesterone 
secretion. Although these results from luteal slice incubations were similar to those 
from dispersed monolayer culture of porcine luteal cells at the same stages (Huang et 
al., 1991), IGF-I distinctly augmented progesterone production at Day 110 and re­
laxin production at Days 110 and 113 when co-incubated with gonadotrophins. These 
patterns of relaxin and progesterone secretion by incubated luteal slices parallel the 
relaxin surge release that is coincident with decreased progesterone concentrations in 
the peripheral blood at the same stages of pregnant and hysterectomized gilts (Felder 
et al., 1986, 1988; Li et al., 1989). We interpret these results to indicate that aging 
corpora lutea may be programmed to have an inherent life span of approximately 113 
days. 
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PRL is luteotrophic for aging corpora lutea in this species (Felder et al., 1988; Li 
et al., 1989). Administration of PRL or LH in vivo sustained or increased relaxin and 
progesterone concentrations in the peripheral blood, which maintained or increased 
luteal weight. Whether the elevated hormone concentrations result from an increased 
rate of secretion in vivo is unresolved. Results from dispersed monolayers of luteal 
cells in culture indicate that PRL and LH increase the rates of relaxin and proges­
terone secretion (Gregoraszczvk, 1983; Grinwich et al., 1983; Huang et al., 1991). 
Porcine luteal cells have PRL-specific binding receptors (Rolland et al., 1976; Bram-
ley and Menzies, 1987), and LH can stimulate progesterone secretion by these cells 
from the estrous cycle and early pregnancy (Lemon and Loir, 1977; Hunter, 1981; 
Kineman and Rampacek, 1987), which is consistent with the present findings with 
aging corpora lutea. 
In the present study, IGF-I or LH alone did not increase relaxin production, 
whereas a synergistic effect occurred when IGF-I was combined with LH and(or) PRL. 
This synergistic action between IGF-I and gonadotrophin or the combination of the 
three hormones indicates similar mechanisms, or at least some overlap, in their path­
ways to cause progesterone and relaxin synthesis and release. It has been shown that 
porcine granulosa cells may be sites of IGF-I production (Mondschein and Hammond, 
1988), receptors (Baranao and Hammond, 1984), and hormone action (Veldhuis et 
al., 1986, 1987). That IGF-I alone stimulated or potentiated gonadotrophin-induced 
steroidogenesis has been reported in porcine thecal cells (Caubo et al., 1989), bovine 
luteal cells (McArdle and Holtorf, 1989), and rat granulosa cells (Adashi et al., 1985a, 
b). IGF-I binds the membrane receptor that has tyrosine kinase activity. Its action 
may be partly mediated by cAMP because IGF-I can increase adenylate cyclase ac-
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tivity and stimulate cAMP-induced testosterone and progesterone biosynthesis (Lin 
et al., 1987). Dibutryl (db)cAMP has been demonstrated to be a potent stimulator of 
relaxin and progesterone secretion from dispersed aging luteal cells in culture (Huang 
et al., 1991). Alternatively, IGF-I may increase LH receptors and LDL receptors in 
gonadal tissue. This is consistent with the report that IGF-I synergized with FSH 
in the induction of progesterone synthesis by an increase of LH receptor (Adashi et 
al., 1985b) and by an increase of LDL receptors in porcine granulosa cells with no 
change in their affinity (Veldhuis et al., 1987). 
The results of the present study indicate that aging luteal tissues from hys­
terectomized gilts increase relaxin and progesterone production in response to co-
incubation with IGF-I, LH, and PRL on a day-dependent basis. By Day 116, an 
inability to increase progesterone and relaxin secretion signaled the occurrence of 
regression in luteal tissues, which was supported by morphologic evidence in the fine 
structure of these cells at Days 110, 113, and 116. Taken together, the distinct shifts 
in steroid and peptide hormone secretion and production patterns in luteal tissues 
during this brief period indicate that luteal tissue from hysterectomized gilts can 
mimic the events that occur in pregnant gilts at corresponding stages. This implies 
that incubated luteal tissues express their own species-specific life span of approxi­
mately 113 days regardless of whether the uterus and(or) fetuses are present in the 
pig-
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ABSTRACT 
This experiment was designed to determine the effects of relaxin with or without 
estrogen on the growth and development of the uterine cervix of prepubertal gilts. 
Twenty littermate gilts of similar body weight (33 ± 3 kg; mean ± SE) at 80 days 
of age were randomly assigned to four treatments: Vehicle (Control, 1 ml PBS and 
1 ml vegetable oil, 6x, n = 5); Relaxin (Relaxin, 1 ml, 167 /ig/ml, 6x, n = 5); 
Estradiol Benzoate (EB, 1 ml, 2 mg/ml, 6x, n = 5); and Relaxin plus EB (Relaxin 
+ EB, at the same doses, n = 5; im injection, every other day). Twenty four hours 
after the last injection, hysterectomy was performed and the uterine tissues were 
immediately frozen at - 80 C. Samples were taken from the middle portions of the 
cervix and the uterine horns, and dried to a constant weight to determine the dry 
weight and water concentration. Homogenates of uterine horns and cervices were 
analyzed for concentrations and contents of protein, hydroxyproline (collagen index), 
and DNA. Relaxin alone had no significant effect on all parameters (i.e., wet weight, 
Relaxin vs Control: 36 ± 5 vs 28 ± 3 g/uterus, dry weight 5.6 ± 0.6 vs 4.4 ± 0.4 
g/uterus). EB alone increased significantly (P < 0.05) wet weight of the uterus (EB 
vs Control: 85 ± 23 vs 28 ± 3 g/uterus), dry weight (EB vs Control: 14.5 ± 3 vs 4.4 
± 0.4 g/uterus), and hydroxyproline content (EB vs Control: 47.2 ± 13 vs 12.6 ± 
4 mg/cervix). In the presence of EB, relaxin treatment increased all measurements 
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compared with Control (i. e., wet weight, Relaxin+EB vs EB: 136 ± 34 vs 28 ± 
3 g/uterus). Compared with EB, Relaxin+EB significantly (P < 0.05) increased 
the uterine wet weight (Relaxin+EB vs EB: 136 ± 34 vs 85 ± 23 g/uterus), the 
hydroxyproline content (Relaxin+EB vs EB: 91 ± 29 vs 47 ± 13 mg/cervix), and 
DNA content (Relaxin+EB vs EB: 8.1 ± 2 vs 5.4 ± 1 mg/cervix). These results 
indicate that the growth-promoting effects of relaxin on the uterus and cervix may 
be, at least partially, estrogen-dependent, and that the growth and development of 
uterus and cervix can be accelerated by hormone combination of relaxin and estrogen. 
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INTRODUCTION 
Relaxin is a pregnancy-associated polypeptide hormone (Kemp and Niall, 1984; 
Porter and Watts 1986; Anderson, 1987; Sherwood, 1988). Its primary target organs 
appear to be the components of reproductive system such as the uterus and cervix 
(Hisaw and Zarrow, 1950; Steinetz et al., 1957; Too et al., 1986). The physiologi­
cal actions of relaxin prepare the birth canal for accommodation the growth of the 
conceptus(es) and to facilitate parturition (Downing and Sherwood, 1985a; Musah 
et al., 1986a, 1986b, 1987, 1988; Bagna et al., 1991). The specific effects of this 
hormone include growth-promotion of the uterus and cervix (Steinetz et al., 1957; 
Vasilenko et al., 1980, 1981, 1986, 1987), suppression of uterine contractile activ­
ity (Porter and Watts, 1986; Downing and Sherwood, 1985b), and dilatation of the 
uterine cervix (Zarrow et al., 1956; Kertiles and Anderson, 1979; Downing and Sher­
wood, 1985c, 1986). Most of these biological effects are estrogen-dependent (Brody 
and Wiqvist, 1961; O'Day et al., 1989). In pigs, relaxin has been reported to stim­
ulate the growth of uterus (Galvin et al., 1988; Hall et al., 1990), cervix (Sherwood 
et al., 1988; Eldridge-White et al., 1989; O'Day et al., 1989), and mammary glands 
(Hurley et al., 1991). Whether these effects of relaxin on uterine tissues are estrogen 
dependent or just augmented by estrogen is not fully described (Hall et al., 1990). 
Furthermore, whether the growth promoting effects induced by relaxin and estrogen 
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increased extracellular components and/or cause a simultaneous increase in cellular 
components (hyperplasia and/or hypertrophy) is not delineated. Thus, the present 
study was designed to determine the effects of relaxin alone or in conjunction with 
estrogen on the growth and modification of uterine connective tissue of prepubertal 
gilts by measuring the concentration and contents of DNA, protein, and collagen in 
the tissues. 
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MATERIALS AND METHODS 
Chemicals and hormones 
Deoxyribonucleic acid (DNA, D-8899, calf thymus, sodium salt), bisbenzimide 
trihydrochloride Hoechst 33258 (H33258, B-2883), hydroxy-L-proline (Crystalline, 
H6002), /^-estradiol 3-benzoate (EE, E-9000), were obtained from Sigma Chemical 
Co., (St. Louis, MO), /j-dimethylamino benzaldehyde was obtained from Aldrich 
Chemical Co. (Milwaukee, WI). Protein assay kit was from BioRad Chemical (Bio-
Rad 500-0006, Richmond, CA). Porcine relaxin (3,000 units/mg) was purified accord­
ing to procedures described previously (Bitllesbach and Schwabe, 1985). 
Animals and hormone treatments 
Twenty purebred Yorkshire gilts, 80 days old, were used in this experiment. 
The animals were housed indoors under controlled light and temperature conditions 
during the experimental period. There were four treatment groups: Vehicle (Control, 
1 ml PBS and 1 ml vegetable oil, 6x, n = 5); Relaxin (Relaxin, 1 ml, 167 /ig/ml, 6x, 
n = 5); Estradiol Benzoate (EB, 1 ml, 2 mg/ml, 6x, n = 5); and Relaxin plus EB 
(Relaxin -f EB, at the same doses, n = 5; im injection, every other day). Each time, 
to eliminate variation of individual animals from different litters, four littermates 
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at similar body weight from a sow were randomly assigned to the four treatments. 
Hysterectomy was performed 24 hr after the last hormone or placebo injection. Uteri 
were trimmed of the broad ligament, oviducts, and ovaries. The fresh weights (wet 
weight) of the uterine horns and uterine cervix were determined. Two segments from 
the middle portion of each uterine horn and cervix were excised, weighed; one was 
immediately frozen at - 80°C until assayed for DNA, protein, and hydroxyproline 
contents, the other was dried to a constant weight in a oven at 100°C to determine 
the dry weight and water content. 
DNA determination 
DNA concentrations and contents in tissue homogenates were quantitated by 
using the methods of LaBarca and Paigen (1980) with modification. The tissue sam­
ples of the cervix and uterine horns were homogenized using a polytron (Brinkmann, 
Switzerland) in a buffer (0.05 M NaHgPO^, 2 M NaCl, 2 mM EDTA, pH 7.4). Assay 
standard was prepared from calf thymus DNA in the assay buffer (0.05 M NaH2P0<j., 
2 M NaCl, 2 mM EDTA, pH 7.4). One milligram wet weight tissue per milliliter was 
used in the assay. Aliquots of homogenates were mixed equally with buffer contain­
ing H33258 to final concentrations of 1.0 /tg/ml. Relative fluorescence was measured 
with a Spectrofluorometer (Gilford, Oberlin, Ohio). The sensitivity of the assay was 
5 ng DNA/ml. 
Protein assay 
The protein contents in tissue homogenates were determined spectrophotomet-
rically by using an acidic solution of Coomassie Brilliant Blue G-250 (BioRad), and 
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measuring the absorbance at 595 nM. The assay standard was crystalline bovine 
serum albumin (Armour Pharmaceutical Co., Chicago, IL). The standard curve is 
linear to 800 fig and sensitive to 25 /ig. 
Hydroxyproline determination 
The homogenates of the uterine horn and cervix were analyzed for hydroxyproline 
concentration and content. To pyrex tubes containing the homogenates of the uterine 
or cervical tissue were added an equal volume of HCl (3 N), and autoclaved for 12 h. 
The resultant acid hydrolysates were dried down and 1.0 ml H2O was added to each 
tube. To each sample and standard tubes (1.0 ml, concentrations: 0, 0.5, 1.0, 1.5, 
2.0, 3.0, 5.0, 7.5 and 15.0 hydroxyl-L-proline /ig/ml), 1.0 ml fresh mixture of 0.01 M 
CUSO4 : 2.5 M NaOH (1:1 v/v) was added and mixed well; then 100 fil 30% HgOg 
was added to each tube and mixed. After 5 min, 100 /il FeSO^ (0.05 M) was added 
to each tube and mixed for 6 min. All tubes were placed in an ice bath for 5 min, 
and 3 ml /o-dimethylamino benzaldehyde was added to each tube and incubated for 
16 min in 70°C water bath. After cooling the tube, absorbance was measured at 550 
nM in a Spectronic 20 (Bausch and Lomb Inc., Rochester, NY). The standard curve 
is linear to 15 fig and sensitive to 0.5 //g/ml. 
Statistical analysis 
The experimental unit was individual animal. The data were analyzed using 
the general linear models procedures (SAS, 1985). The model included the main 
effects of treatments, litter, and their interaction. The interaction of treatment by 
litter was used to be error term to test significance and P < 0.05 was considered 
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significant. Comparisons between the control and the treatments were made by the 
least significant difference (Snedecor and Cochran, 1989). 
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RESULTS 
The data of wet weight (A) and dry weight(B) of the uterus are presented in 
Figure 1. Relaxin alone did not significantly increase the wet weight (RLX vs CNTL; 
36 ± 5 vs 28 ± 3 g/uterus; mean ± SE) or dry weight (RLX vs CNTL: 6.1 ± 0.6 vs 4.6 
± 0.4 g/uterus) of the uterus. Estrogen or relaxin plus estrogen increased (P < 0.05 
and P < 0.01, respectively) wet weight and dry weight of the uterus compared with 
control. Compared with estrogen alone, the relaxin plus estrogen significantly (P < 
0.05) stimulated the growth of the uterus; this effect can be viewed as a relaxin effect 
being estrogen-dependent or a synergistic interaction between relaxin and estrogen. 
The effects of hormonal treatments on wet weight (A) and dry weight(B) of the 
cervix are presented in Figure 2. Relaxin alone did not significantly increase the wet 
weight (RLX vs CNTL; 4.1 ± 0.9 vs 3.3 ± 0.5 g/cervix) or dry weight (RLX vs 
CNTL: 0.72 ± 0.2 vs 0.58 ±0.1 g/cervix) of the cervix. Estrogen or relaxin plus 
estrogen increased (P < 0.05 and P < 0.01, respectively) wet weight and dry weight 
of the cervix compared with control. 
The effects of relaxin and estrogen on protein, hydroxyproline and DNA contents 
are presented in Figure 3. Relaxin alone had no effect on DNA (RLX vs CNTL: 2.4 
± 0.7 vs 2.1 ± 0.6 mg/cervix), protein (RLX vs CNTL: 244 ± 80 vs 190 ± 32 
mg/cervix), and, hydroxyproline (RLX vs CNTL: 18 ± 6 vs 13 ± 4 mg/cervix) 
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Figure 1: Wet weight (A) and dry weight (B) of the uterus following injection (i.m.) 
of vehicle (CNTL, 1 ml PBS, 6 x/2 week), relaxin (RLX, 167 /ig/ml, 1 
ml, 6 x/2 week), estradiol benzoate (EB, 2 mg, 6 x/2 week), and relaxin 
plus estradiol benzoate (RLXEB) into prepubertal gilts of 80 days old (n 
= 5). Values are mean ± SE; a and c : P < 0.05; b: P < 0.01 compared 
with CNTL; a differs from b at P < 0.05. 
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Figure 2: Wet weight (A) and dry weight (B) of the cervix following injection (i.in.) 
of vehicle (CNTL, 1 ml PBS, 6 x/2 week), relaxin (RLX, 167 //g/ml, 1 
ml, 6 x/2 week), estradiol benzoate (EB, 2 mg, 6 x/2 week), and relaxin 
plus estradiol benzoate (RLXEB) into prepubertal gilts of 80 days old (n 
= 5). Values are mean ± SE; a and b : P < 0.05; c: P < 0.01 compared 
with CNTL; a differs from c at P < 0.05. 
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Figure 3: DNA (A), protein (B), and hydroxyproline (C) contents of the cervix 
following injection (i.m.) of vehicle (CNTL, 1 ml PBS, 6 x/2 week), 
relaxin (RLX, 167 /tg/ml, 1 ml, 6 x/2 week), estradiol benzoate (EB, 
2 mg, 6 x/2 week), and relaxin plus estradiol benzoate (RLXEB) into 
prepubertal gilts of 80 days old (n = 5). Values are mean ± SE; a and c 
: P < 0.05; b: P < 0.01 compared with CNTL; a differs from b at P < 
0.05. 
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contents. Estrogen or relaxin plus estrogen stimulated significantly (P < 0.05 and 
P < 0.01, respectively) protein, hydroxy proline, and DNA contents compared with 
control. The synergistic interaction between relaxin and estrogen or relaxin effect in 
the presence of estrogen was significant (P < 0.05) on the protein (EB vs RLXEB: 
728 ± 233 vs 979 ± 231 mg/cervix), hydroxyproline (EB vs RLXEB: 47 ± 13 vs 91 
± 29 mg/cervix), and DNA (5.4 ± 1 vs 8.1 ± 2 mg/cervix) contents. 
Water concentrations of the uterine horn and cervix following relaxin and estro­
gen treatment are presented in Figure 4. No significant effects of treatments were 
detected. The overall water concentration of the cervix was about 81%, the uterine 
horn was 83%. The ratios of total protein (mg/cervix) to total DNA (mg/cervix) 
were determined (Figure 5). Relaxin and/or estrogen treatments did not cause a 
significant increase in the tissue hypertrophy index. 
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Figure 4: Water concentration of the cervix following injection (i.m.) of vehicle 
(CNTL, 1 ml PBS, 6 x/2 week), relaxin (RLX, 167 /ig/ml, 1 ml, 6 x/2 
week), estradiol benzoate (EB, 2 mg, 6 x/2 week), and relaxin plus estra­
diol benzoate (RLXEB) into prepubertal gilts of 80 days old (n = 5). 
Values are mean i SE. No significant effects are detected. 
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Figure 5; The ratio (hypertrophy index) of protein content (mg) to DNA content 
(//g) of the cervix following injection (i.m.) of vehicle (CNTL, 1 ml PBS, 6 
x/2 week), relaxin (RLX, 167 /fg/ml, 1 ml, 6 x/2 week), estradiol benzoate 
(EB, 2 mg, 6 x/2 week), and relaxin plus estradiol benzoate (RLXEB) 
into prepubertal gilts of 80 days old (n = 5). Values are mean ± SE. No 
significant effects are detected. 
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DISCUSSION 
The present results indicate that the growth and development of the uterus and 
cervix of the prepubertal pigs can be accelerated by relaxin combined with estro­
gen. After 2 weeks of sequential injections with relaxin and estrogen, the uteri of the 
prepubertal pigs were 5-fold heavier than those of vehicle-injected animals. This in­
dicates that the normal growth and developnaent can be stimulated without affecting 
somatic growth since the body weights at the end of treatment between the treat­
ment and control animals were not different (data not shown). Similar phenomena 
were seen during precocious puberty where growth of sexual organs was greater than 
other somatic organs. Whether the mechanisms underlying these two events were 
similar or not is unclear. In present studies, the ratio of protein to DNA (an index 
of tissue hypertrophy or cell size) was similar. The ratios of hydroxyproline to DNA 
or protein were not significant among the four treatment groups (data not shown). 
Thus, the proportional growth in uterine tissue is assured. 
In rats and mice, the effects of relaxin on the uterine tissues include an increase 
in uterine water content, wet weight, dry weight, glycogen content, and nitrogen 
content (Steinetz et al., 1957; Jablonski and Velardo; 1957; Brennan and Zarrow, 
1959; Kroc et al., 1959; Hall, 1960; Brody and Wiqvist, 1961; Hall, 1965; Wada and 
Turner, 1961 ); these early studies examined the short term effects and employed 
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partially purified porcine relaxin. However, these conclusions were confirmed with 
highly purified porcine relaxin in the recent studies in the rat and mouse (Frieden 
and Adams, 1985; Vasilenko et al., 1986; Vasilenko and Mead, 1987), in the pig 
(Galvin et al., 1988; Hall et al., 1990), and extended in the present study. In this 
study, the long term effects of relaxin were determined during 2 weeks of hormone 
treatment. Thus, the water content or concentration showed little difference between 
the hormone-treated and vehicle-treated animals (Vasilenko et al., 1980). In contrast, 
the short term effects of high dose relaxin were always reported to stimulate water 
imbibition (Steinetz et al., 1957; Zarrow and Brennan, 1957; Vasilenko and Mead, 
1987; Hall et al., 1990). 
Galvin et al. (1988) reported that four daily injections with a total of 2 mg 
relaxin per day increased significantly the uterine wet weight and uterine circum­
ference of unilaterally ovariectomized gilts. These results were confirmed by their 
second consecutive experiment on mated gilts from days 6 to 11, and confirmed re­
sults reported here. However, Galvin and colleagues (1988) found that the DNA and 
protein contents of the uterus were not significantly different between the relaxin-
treated and saline treated animals. It seems that increase in uterine wet weight and 
circumference may be due to the water imbibition caused by this high dose of relaxin 
treatment over short time period of the experiment. In contrast, the present study 
showed that uterine weights, dry weights of the uterus and cervix were significantly 
increased along with the contents of DNA, protein, and hydroxyproline of the uterus 
(data not shown) and cervix. 
Hall et al. (1990) reported that relaxin stimulated uterine growth in the pre­
pubertal gilts without prior exposure to estrogen. This implies that the uterotropic 
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effect of relaxin in pig may not be estrogen dependent. However, the synergistic in­
teraction between relaxin and estrogen have been reported by several groups (Wada 
and Turner, 1961; Vasilenko et al., 1986; O'Day et al., 1989) and in the present 
study. Furthermore, the relaxin dosage used in this study was very low (a total of 
1.0 mg/pig over 2 weeks) compared with much greater dosages used in other studies 
(4.5 mg/54 hr/pig; Hall et al., 1990). This low dosage of relaxin used in the present 
study consistently increased uterine weight, as was seen with higher dose in other 
studies. 
The mechanism of the synergistic interaction between relaxin and estrogen was 
not fully understood, but at least the part of this interaction may be due to estrogen's 
ability to induce an increase in the number of relaxin receptors in the uterine cervical 
cells as demonstrated in Section III. Nevertheless, stimulation of collagen and non-
collagen protein production and secretion from these cells by relaxin was augmented 
in the presence of estrogen. This is also supported by the findings from the rat and 
pig (Mercado-Simmen et al., 1982a, b). The effects of estrogen on the uterine tissue 
may include activation of protooncogenes which encode nuclear regulatory proteins 
(Loose-Michell, 1988), growth factors and their receptors (Mukku and Stancel, 1985), 
and cAMP-independent protien kinase (Sharoni et al., 1984). 
In summary, the present results show that the growth and development of the 
uterus and cervix can be accelerated by treatment of relaxin and estrogen. Although 
it is not known whether the pig at this stage contains relaxin receptors after relaxin 
and estrogen stimulation, the results reported here indicate that relaxin regulates the 
growth and development of the uterus and cervix during pregnancy as well as during 
prepubertal period. 
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ABSTRACT 
To investigate relaxin's role in the connective tissue remodeling in the porcine 
uterine cervix, collagenase-dispersed cells (3 x 10^ cells/well) from the uterine cervix 
of gilts (n = 5) were incubated with porcine relaxin (0, 100, 500 ng/ml), or estradiol 
benzoate (EB, 0, 50, 250 ng/ml) alone or in combination. The roles of (Bu)2cAMP 
(0, 0.1, 1.0, 5.0 mM), actinomycin D (0, 500 ng/ml), and cycloheximide (0, 500 
ng/ml) in the relaxin-estrogen-induced collagen secretion also were determined. In 
the first experiment, the addition of relaxin alone (P < O.05) or in combination with 
EB increased protein secretion into the medium. The hydroxyproline content in the 
medium was increased (P < 0.05) only by the presence of relaxin and estrogen at the 
same time. Both actinomycin D and cycloheximide inhibited hydroxyproline secre­
tion induced by combined relaxin and estrogen treatment. (Bu)2cAMP was a potent 
enhancer of hydroxyproline secretion in a dose dependent way. The second experi­
ment was designed to determine the role of estrogen in regulating relaxin receptors 
in these uterine cervical cells. The number of relaxin binding sites on these cells 
was quantified by specific binding of a saturating dose of ^^^I-labeled monotyrosyl 
relaxin at optimal conditions. Estrogen benzoate at doses of 0.4-50 ng/ml increased 
the number of relaxin binding sites in a time- and dose-dependent manner. The 
Scatchard plot exhibited downward curvillinearity which implied that there are two 
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classes of relaxin binding sites. Taken together, these results indicate that relaxin 
stimulates hydroxyproline secretion in the presence of estrogen and this effect was a 
protein and RNA synthesis dependent process. Estrogen plays a role in augmenting 
the sensitivity of uterine cervical cells to relaxin in the pig. 
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INTRODUCTION 
One of the primary target organs for relaxin biological actions is the uterine 
cervix. The remarkable effects of relaxin on this organ include inducing growth and 
remodeling of connective tissue and cervical cells to accommodate pregnancy and 
parturition (Kertiles and Anderson, 1979; Eldridge-White et al., 1989; Bagna et al.^ 
1991). The related physiological and clinical observations include softening, ripening, 
and dilating the cervix, and facilitating delivery of the young (Zarrow et al., 1956; 
Sherwood, 1988). The underlying molecular and cellular mechanisms for these actions 
are still obscure. Collagen is the most abundant protein in the cervix and plays a key 
role in connective tissue remodeling. Collagen metabolism and fibroblastic activity 
in the connective tissues seem to be the prime target for relaxin action. Relaxin was 
reported to increase collagen content in vivo (Vasilenko and Mead, 1987) and in vitro 
(Frieden and Adams, 1985) and to promote incorporation of proline into the collagen 
in mammary fibroblasts (Sheffield and Anderson, 1984). Relaxin binding to cervical 
tissue was reported in the rat (Weiss and Bryant-Greenwood, 1982; Mercado-Simmen 
et al., 1982a), in the pig (Mercado-Simmen et al., 1982b), and in human and mouse 
fibroblasts (Mercado-Simmen et al., 1980), but the role of estrogen in regulating the 
number of relaxin receptors was not delineated and direct evidence for relaxin's effects 
on collagen synthesis in the cervical cells was not seen. The present study was carried 
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out to determine the role of relaxin on the collagen synthesis of porcine cervical cells 
in the presence or absence of estrogen, and the role of estrogen in regulating the 
number of relaxin receptors. 
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MATERIALS AND METHODS 
Chemicals and reagents 
The following reagents were obtained from Sigma Chemical Co., St Louis, MO: 
Dulbecco's Modified Eagle's Medium (DMEM, D5523); collagenase (type II, 1180 
units/mg, lot 105F-6825); antibiotic antimycotic solution (A4668); hydroxy-L-proline 
(crystalline, H6002); N®-2'-0 dibutyryl adenosine 3', 5'- cyclic monophosphate monosodium 
[(Bu)2cAMP, D6627]; trypsin inhibitor (T6522); actinomycin D (A1410); cyclohex-
imide (C6255); /9-dimethylamino benzaldehyde (D2004); and bovine calf serum (Heat 
inactivated, C5280). The protein assay kit, BioRad Protein Assay Dye, was from 
BioRad Chemical (BioRad, 500-0006). Porcine relaxin (3000 unit/mg) was purified 
according to procedures described previously (Bitllesbach and Schwabe, 1985). 
Animals and cell dispersion 
All uterine cervices were obtained aseptically by hysterectomy of purebred York­
shire gilts (n = 5) at day 8 (estrus = 0). Upon uterine removal, the middle portion 
of the cervix was immediately excised; the inner layer, the epithelium, and the outer 
layer, the perimetrium, were torn away. The remaining tissue was minced and the 
blood and cell debris were washed away. The minced tissue was subjected to collage-
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nase dissociation procedure described by Huang et al. (1991). Since the tissue upon 
the removal from the animal was immediately processed with prewarmed medium 
without cold shock, cell viability was high with an average of 95% as determined by 
the trypan blue exclusion method. 
Cell culture and hormone treatments 
Treatments consisted of 3 x 10^ cells/well incubated with purified porcine relaxin 
(0, 100, 500 ng/ml) or estradiol benzoate (0, 50, 250 ng/ml) or in a 2 x 2 factorial 
combination. The cell culture was performed in 1.0 ml DMEM without serum for 
48 h under the conditions of 37°C, 5% COg, saturated humidity. Another series of 
experiments were carried out to determine the roles of actinomycin D (0, 500 ng/ml), 
cycloheximide (0, 500 ng/ml), and (Bu)2cAMP (0, 0.1, 1.0, 5.0 mM) on the collagen 
secretion processes. 
Hydroxyproline assay 
At the end of culture, the medium was aspirated from each well, centrifuged 
to remove the cell debris, and transferred to a pyrex tube; an equal volume of HCl 
(3 N) was added to the medium and then autoclaved for 12 h. The resultant acid 
hydrolysates were dried down and 1.0 ml H2O was added to each tube. To each 
sample and standard tubes (1 ml, concentrations: 0,0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 5.0, 
7.5 and 15.0 hydroxy-L-proline /itg/ml), 1.0 ml fresh mixture of 0.01 M CuSO^ : 2.5 
M NaOH (1:1 v/v) was added and mixed well; then, 100 /il 30% H2O2 was added 
to each tube, mixed and waited for 5 min. Then, 100 pà FeSO^ (0.05 M) was added 
to each tube and mixed for 6 min. All tubes were placed in an ice bath for 5 min. 
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and 3 ml /o-dimethylamino benzaldehyde was added to each tube and incubated for 
16 min in 70°C water bath. After cooling the tube absorbance was measured at 550 
nM in a Spectronic 20 (Bausch and Lomb Inc., Rochester, NY). The standard curve 
is linear to 15 /(g and sensitive to 0.25-0.5 /ig. 
Protein determination 
The protein content in the cultured medium was determined spectrophotomet-
rically by using an acidic solution of Coomassie Brilliant Blue G-250, and measuring 
the absorbance at 595 nM. The assay standard was crystalline bovine serum albumin 
(BSA; Armour Pharmaceutical Co., Chicago, IL). The standard curve is linear to 800 
/ig and sensitive to 50 //g. 
lodination of porcine relaxin 
Porcine monotyrosyl relaxin (3,000 U/mg) was prepared using N-formyltyrosine 
N-hydroxy succinamide (Schwabe, 1983). Na^^^I (10 /il; 1 mCi; IMS 30, Amersham 
Corp., Arlington Heights, IL) was added to 5 fig monotyrosyl relaxin (50 /il 0.5 M 
phosphate buffer [PB], pH 7.5). The reaction was started by chloramine-T (25 fil of 
a 2 mg/ml solution of 0.05 M PB) in an ice bath and terminated after 60 sec with 
sodium metabisulfite (100 /il of a 1 mg/ml solution in 0.05 M PB). The contents 
were applied to a Bio-Gel P6 (100-200 mesh; Bio-Rad Laboratories, Riverside, CA) 
column, rinsed with 100 /tl KI, applied to the column again, and eluted with 0.05 M 
PB. 
Analysis of relaxin receptors 
The methods of relaxin receptor assays were followed as those described by 
McMurtry et al. (1980) and Mercado-Simmen et al. (1980) with some modifications. 
Briefly, after overnight incubation (14 h) in 20% bovine calf serum (BCS); the cell 
suspension was centrifuged to remove the BCS, and the cell pellet was resuspended 
in DMEM. An aliquot of the cell suspension (5 x 10^ cells/tube) was put in a plastic 
tube (12 X 75 mm) and incubated for 8 h in the presence of EB, 50 ng/ml. At the 
end of the incubation, the cell suspension was centrifuged to remove the incubation 
medium and 100 ^1 binding buffer (DMEM, 0.1% BSA) was added to resuspended 
the cell pellet and 100 /il ^^^I-labeled monotyrosylated porcine relaxin (80,000 cpm; 
specific activity = 110.6 /iCi//ig) in Tris buffer (0.15 mM, pH 7.5. 0.1% BSA) was 
added, additional 100 jxl DMEM with or without unlabeled relaxin in Tris buffer. 
The equilibrium time (optimal time) of reaction at 4° C was determined from 1 to 
6 h at 1 h interval and at 4 h the reaction reached a limited equilibrium. Thus, all 
following binding assays were carried out for 4 h. After incubation at 4°C for 4 h, 
3 ml ice-cold Tris buffer (0.05 M, 1% BSA, pH 7.5) was added and the tubes were 
immediately centrifuged at 2,000 x g for 20 min. The supernatant was decanted and 
radioactivity in the pellet was quantified in a Packard autogamma counter (Cobra 
5000A). The background was subtracted, the decay of radioactivity was corrected, 
and the specific binding or net binding of labeled relaxin was obtained by subtracting 
from total binding the amount of labeled hormone bound in the presence of 20 /tg/ml 
of unlabeled relaxin. The Scatchard plot was carried out by varying the concentration 
of labeled relaxin from 10~^^ to 10~^ M. 
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Statistical analysis 
The experiment unit was 5 x 10^ cells/well. The data are expressed as the mean 
± SEM. The treatment effects of hormones on hydroxyproline and protein secre­
tion were determined by analysis of variance, followed by the least square difference 
(Snedecor and Cochran, 1989). P < 0.05 was considered significant. Receptor assay 
data were expressed as percentage of the mean cpm of ^^^I-relaxin bound to cells 
in the control group (control =100%). Mean percentage values for all replicates for 
each treatment were calculated. The effects of EB treatment and time incubation 
were analyzed by least square analysis of variance using the General Linear Models 
procedure of the Statistical Analysis System (SAS, 1985). 
83 
RESULTS 
Relative to the control (0 h incubation time with EB), the number of relaxin re­
ceptors increased with incubation time in the presence of EB (50 ng/ml) and reached 
significant level (P < 0.05) at 8 and 16 h (Figure 1). The number of relaxin receptors 
increased as the dose of EB was increased from 0.4 to 250 ng/ml (Figure 2). The 
increase in receptor number was significant (P < 0.05) at dose of 0.4 ng/ml and (P < 
0.01) at EB doses from 2 to 250 ng/ml. Scatchard plot analysis of relaxin binding to 
cervical cells treated with EB 50 ng/ml for 8 h exhibited downward curving (Figure 3) 
and implied that there are two classes of binding sites. Competition curve for labeled 
relaxin to porcine cervical cells by unlabeled relaxin was presented at Figure 4. When 
1 ng/ml unlabeled relaxin was added to the binding system, about 30-40% of bound 
labeled relaxin was replaced. However, the percentage of replacement decreased with 
increased unlabeled relaxin. 
Effects of relaxin and EB on secretion of hydroxyproline from the porcine cervical 
cells were presented at Figure 5 and 6. Either relaxin or EB alone did not induce 
significant amount of hydroxyproline secreted into the medium (Figure 5), but in 
the presence of EB, relaxin stimulated hydroxyproline secretion (P < 0.05) into the 
culture medium by the cervical cells. (Bu)2cAMP was potent enhancer (P < 0.01) 
for hydroxyproline secretion in a dose dependent way (Figure 6). Actinomycin D 
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Duration of Incubation (Hours) 
Figure 1: Effects of incubation time with estradiol benzoate (EB 50 ng/ml) on the 
number of relaxin binding sites in porcine uterine cervical cells (8 h incuba­
tion). Values are mean ± pooled SE, each bar represents 6 determinations 
of 2 separate experiments, a: P < 0.05 (compared with values at 0 h). 
At the dose of 50 ng/ml, the specific binding was 3.7% of added labeled 
hormone. 
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0.4 1 0 50 250 
Estradiol Benzoate (ng/ml) 
Effects of estradiol benzoate dosage on the number of relaxin binding 
sites in porcine uterine cervical cells (8 h incubation). Values are mean ± 
experiments. 
% -n^ ; ; [ ^  (compared with values at 0 ng/ml). At the dose 
of oO ng/ml, the specific binding was 3.5% of added labeled hormone. 
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Figure 3: Scatchard plot of the data from study of the concentration (10 ^ - 10 
M) of ^^^I-relaxin binding to porcine uterine cervical cells. The binding 
assay was carried out for 4 h at 4°C. 
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Figure 4: Competition for labeled relaxin to porcine uterine cervical cells by un­
labeled relaxin. Cells were incubated in the presence of labeled relaxin 
and unlabeled relaxin in the concentration range 1-10,000 ng/ml for 4 
h at 4°C and centrifuged. Values are mean of 6 determinations from 2 
separate experiments. 
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reduced the basal and relaxin-EB-induced hydroxyproline secretion (P < 0.05). Cy-
cloheximide blocked the stimulatory effects of relaxin-EB (P <• 0.05) on collagen 
secretion. Protein secretion (Figure 7) was enhanced by relaxin treatment (P < 
0.05), but EB stimulated protein secretion to a lesser degree. In the presence of EB, 
relaxin increased the protein secretion (P < 0.05). 
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Figure 5: Effects of estradiol benzoate (EB at 0, 50, 250 ng/ml) and relaxin (RLX) 
at 0, 100, 500 ng/ml on the hydroxyproline (collagen index) secreted by 
porcine uterine cervical cells during 48 h at 37°C. Values are mean ± SE, 
each bar represents 15 determinations from 5 separate experiments, a: P 
< 0.05 compared with control. 
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Figure 6: Effects of dibutyryl cyclic AMP ([BulgcAMP), actinomycin D (Act D, 500 
ng/ml) and cycloheximide (Cyclo 500 ng/ml) on the relaxin and estradiol 
benzoate (RLX, lOOng/ml; EB 50 ng/ml) stimulated hydroxyproline se­
cretion (collagen index) by porcine uterine cervical cells. Values are mean 
± SE, each bar represents 9 determinations from 3 separate experiments, 
a: P < 0.05; b; P < 0.01 compared with control, c: P < 0.05 compared 
with RLX-EB. 
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Figure 7: Effects of estradiol benzoate (EB at 0, 50, 250 ng/ml) and relaxin (RLX) 
at 0, 100, 500 ng/ml on the protein secreted into the culture medium by 
porcine uterine cervical cells during 48 h at 37°C. Values are mean ± SE, 
each bar represents 15 determinations from 5 separate experiments, a; P 
< 0.05 compared with control. 
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DISCUSSION 
The results from this study indicate that estrogen elicits an increase in number of 
relaxin receptors which is time- and dose-dependent, and that relaxin, in the presence 
of estrogen, stimulates collagen synthesis and secretion, a process required mRNA 
transcription and protein synthesis. Relaxin stimulated collagen and non-collagen 
protein secretion may reflect the growth-promoting effect of this hormone on the 
cervix as reported earlier in the rat (Vasilenko et al., 1980; Downing and Sherwood, 
1986; Vasilenko and Mead, 1987) and in the pig (O'Day et al., 1989; Hall et al., 
1990). This study reveals that the priming effect of estrogen for relaxin's action 
or a synergistic interaction between relaxin and estrogen is, at least partially, the 
result of estrogen's induction of specific receptors on the target cells for relaxin. This 
interpretation is compatible with the observation that circulating concentrations of 
estrogen increase earlier than those of relaxin during mid- and late-pregnancy, a 
time when the growth and remodeling of uterine cervix occur (Anderson et al., 1983; 
Eldridge-White et al., 1989; O'Day et al., 1989). 
The rat relaxin receptor is under hormonal control by estrogen and the number 
of receptors increases remarkably after estrogen treatment (Mercado-Simmen et al., 
1982a), but no direct correlation has been made to relate specific relaxin binding 
with any biological response. In the present study, increased in numbers of relaxin 
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receptors induced by estrogen were linked to the synergistic action of relaxin and 
estrogen on the collagen synthesis and secretion by the uterine cervical cells. In a 
time- and dose-dependent manner, estrogen increases the number of relaxin receptors 
and thus augments the sensitivity of the uterine cervical cells to relaxin treatment. 
The Scatchard plot of relaxin binding to uterine cervical cells shows downward 
curvilinearity which is consistent with previous results in the rat (Mercado-Simmen 
et al., 1980). the downward curve of the Scatchard plot could be caused by either 
heterogeneity (in this case, two classes) of binding sites (Mercado-Simmen et al., 1980) 
or negative cooperativity (Weintraub, 1990). No attempt was made to determine the 
concentrations of high and low affinity binding sites by extrapolation of the data in 
the present study. 
The cyclic AMP analog, (Bu)2cAMP, also stimulated the secretion of collagen 
by these cervical cells as does relaxin. This finding supports the idea that relaxin's 
mechanism of action could be via a cAMP dependent pathway since cAMP concentra­
tions can be increased by relaxin treatments in target organs (Cheah and Sherwood, 
1980; Judson et al., 1980; Chen et al., 1988). The results of this study demonstrate 
that actinomycin D, as well as cycloheximide blocks the stimulatory effect of relaxin 
and estrogen on collagen secretion by cervical cells. Actinomycin D and cyclohex­
imide are general inhibitors of RNA and protein synthesis, respectively. Thus, this 
finding suggests that relaxin- and estrogen-stimulated collagen secretion is a process 
requiring mRNA transcription and protein synthesis, and it further indicates that 
collagen secreted into cultured media was a product of transcription and translation 
and not due to active secretion from previous intracellular stores. 
The iodinated relaxin binding by uterine cervical cells was time dependent (data 
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not shown) and reversible which is supported by the displacement data (Figure 4). 
Physiological concentrations of unlabeled relaxin (1- 10 ng/ml) significantly displaced 
a portion of bound labeled hormone. This displacement curve is similar to that 
described by Mercado-Simmen et al. (1980). Differences between the two curves 
probably result from the two different temperatures used (4° vs 37° C) in these two 
studies. 
In summary, estrogen plays a key role in augmenting the sensitivity of and 
in preparing the cervical cells to respond to relaxin challenge. In the presence of 
estrogen, relaxin stimulates collagen synthesis and secretion by these uterine cervical 
cells. This provides first direct evidence of relaxin's action on the remodeling and 
growth of the uterine cervix in the pig. 
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ABSTRACT 
RU 486, a potent progesterone antagonist, and relaxin are capable of inducing 
cervical softening, but little is known about the mechanism(s) by which these hor­
mones affect collagen metabolism of the cervix. This experiment was designed to 
determine the effects of RU 486, progesterone, and relaxin on the rate of proline in­
corporation into the cultured uterine cervical cells of the pig. Collagenase-dispersed 
cells (5 X 10^ cells/tube) from the uterine cervix of gilts in luteal phase were incu­
bated for 8 hr with (1) graded doses of progesterone (1 - 10,000 nM) in the presence 
of 100 nM RU 486, (2) graded doses of RU 486 (1 - 10,000 nM) in the presence of 
100 nM progesterone, (3) relaxin (1 - 10,000 nM). All incubation media were supple­
mented with 1.0 nM of estrogen and 2 /iCi of ^H-proline. At the end of incubation, 
trichloroacetic acid was added to final concentration of 10% and centrifuged to pre­
cipitate proteins. The radioactivities (expressed as counts per minute, CPM) of the 
pellets were determined in a /3-counter. Progesterone increased (P < 0.05) the rate 
of tritiated proline incorporation in a dose of 100 nM with CPM of 1310 ± 183 com­
pared with 871 ± 53 CPM at dose of 1.0 nM. RU 486 antagonized the stimulatory 
effect of progesterone on the rate of ^H-proline incorporation. In the presence of 100 
nM progesterone, RU 486 reduced the CPM of ^H-proline incorporated into proteins 
in a dose-dependent manner. At a dose of 10,000 nM, RU 486 (P < 0.05) decreased 
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the CPM to 854 ± 86 compared with 1701 ± 380 at a RU 486 concentration of 1.0 
nM. In a dose-dependent manner, relaxin increases (P < 0.05) the rate of "^H-proline 
incorporation. These results provide a possible explanation of mechanism by which 
RU 486 and relaxin regulate collagen metabolism, leading to cervical softening as 
observed in the clinical subjects and experimental animals. 
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INTRODUCTION 
RU 486, mifepristone, is a synthetic steroid with antiprogesterone and antigluco-
corticoid properties at the hormone receptor (Baulieu, 1988, 1989). RU 486 effectively 
induces abortion in early pregnancy of women (Germain et al., 1985), nonhuman 
primates (Healy et al., 1983) and rats (Garfield et al., 1987), and induces earlier 
parturition in cows (Li et al., 1991a), pigs (Li et al., 1991b) and sheep (Gazal et al., 
1991). The administration of RU 486 to pregnant and cyclic guinea pigs induced 
cervical dilatation, increased the interpubic diameter, and widened the vagina (Elger 
et al., 1987a, b; Chwalisz et al., 1988); this effect of RU 486 on the cervix also was 
seen in pregnant women by cervical softening after RU 486 was orally administrated 
for 12 to 24 hrs (Radestad et al., 1988). The underlying mechanism whereby RU 486 
induces cervical softening and dilating, however, is unknown. The modification in 
collagen metabolism and architecture of connective tissues plays a key role in soft­
ening and dilating the cervix. The collagen consists of up to 80% of the protein in 
the cervix (Danforth, 1980), and proline is the precursor of hydroxyproline which 
is the predominant amino acid in collagen. Convincing evidence indicates that re-
laxin plays a major role in the growth and modification of the cervical connective 
tissue during late pregnancy in many mammalian species (Zarrow et al., 1956; Ker-
tiles and Anderson et at., 1979; Frieden and Adams, 1985; Downing and Sherwood, 
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1986; Eldridge-White et al., 1989; O'Day et al., 1989; Hall et al., 1990). Little is 
known concerning the mechanism(s) whereby relaxin regulates collagen metabolism 
in promoting cervical softening. The present investigation was designed to determine 
whether relaxin, progesterone, and antiprogesterone can affect on ^H-proline incor­
poration (index of collagen metabolism) by cultured uterine cervical cells from the 
pig-
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MATERIALS AND METHODS 
Chemicals and reagents 
RU 486, [RU-38486; 17 hydroxy-11 /3-(4-dimethylaminophenyl) 17-a-(l-propynyl) 
estra-4, 9-dien-3-one] was synthesized and donated by Roussel-UCLAF (Paris, France). 
Progesterone (Cat No: 102722, ICN, Pharmaceuticals Inc. Cleveland, Ohio). ^H-
proline (L-5-^H-proline, TRK.323, 30 Curies/mMol) was obtained from Amersham 
Co. (Arlington Heights, IL). Porcine relaxin (3000 units/mg) was purified according 
to procedures described previously (Biillesbach and Schwabe, 1985). The follow­
ing reagents were obtained from Sigma Chemical Co., St Louis, MO. 17 /^-estradiol 
3-benzoate (EE, E9000), collagenase (type II, 1180 units/mg, lot 105F-6825), Dul-
becco's Modified Eagle's Medium (DMEM, D5523), cell dissociation solution (CDS; 
C5789), Hank's Balance Buffer Solution (HBSS; Ca"^"'" and Mg^"^" free, H2387), 
antibiotic antimycotic solution (A4668), deoxyribonuclease I (DNase I, D4263). 
Animals and cell dispersion 
Hysterectomy was performed to obtain the uterine cervix from purebred York­
shire gilts (n = 4) at day 8 (estrus = 0). The middle portion of the uterine cervix 
was immediately excised, trimmed from the perimetrium and the epithelium, and 
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minced. The cell dispersion procedure was as described by Huang et al. (1991) 
with minor modification. Briefly, the minced pieces of the cervical tissue pieces were 
washed twice with HBSS. To 4 - 5 grams of tissue, 25 ml collagenase solution (2 
mg/ml in mixture of DMEM : CDS [1 : 1, v/v]) was added in a 3-hole Spinner Flask 
containing a magnetic stirring bar. The oxygen gas mixture (95% O2, 5% CO2) 
was supplied every 30 min for 5 min. The flask was incubated at 37 °C water bath 
with 90 rotations (i.e., magnetic bar speed) for 2 hr; at the end of incubation, the 
magnetic bar was stopped for 5 min, the spent medium was decanted and saved, the 
fresh collagenase solution was added. These procedures were repeated until all tissue 
pieces were digested completely. The retained supernatants were pooled and added 
with DNase I (to digest the long chain DNA molecules released from broken cells to 
prevent clumping of cells) in a final concentration of 1000 units/ml, the mixture was 
incubated for 30 min and then centrifuged for 5 min at 150 x g to remove residue 
enzyme and spent medium. The resultant cell pellets were dissolved in HBSS (HBSS 
was Ca"*"^ and free to ease suspending cell pellet). This procedure was re­
peated for at least 2 times. After the last centrifugation, the resultant cell pellet 
was dissolved in culture medium (DMEM, 1.0% antibiotic solution, 1.0 nM EB). The 
cell viability and cell number were determined by trypan blue and hemocytometry 
procedures, respectively. 
Cell culture and hormone treatments 
In a DubnofF Metabolic Shaking Incubator at 37°C, 5% COg, 95% O2 with 
an oscillating speed of 60 cycles/min, the aliquots of cell suspension with 5 x 10^ 
cells/tube were incubated with 2 fiGi of ^H-proline for 2, 4, 6, 8, and 16 hr to 
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establish the time course of ^H-proline incorporation. At 8 hr, maximal ^H-proline 
incorporation was reached. Thus the following incubations were carried out for 8 
hr. The hormone treatments were (1) progesterone at doses of 1.0, 10, 100, 1000, 
and 10,000 nM in the presence of 100 nM RU 486, (2) RU 486 at doses of 1.0, 10, 
100, 1000, and 10,000 nM in the presence of 100 nM progesterone, (3) relaxin at 
doses of 0.0, 1.0, 10, 100, 1000, and 10,000 nM. Each treatment was triplicated and 
the appropriate controls were included to compare the treatment effects of added 
hormones. The steroid hormones were dissolved in 70% ethanol in water and then 
were added to the incubation medium. The final concentration of the ethanol was 
not exceeded 0.01% (v/v) and no effect of this ethanol on ^H-proline incorporation 
was detected. The nonspecific binding of ^H-proline to culture tube or cells was 
determined by incubation of the same amount of ^H-proline without cells or with 
lysed cells. 
Radioactivity determination 
At the end of the incubation, the cells with spent medium were combined with 
trichloroacetic acid in the final concentration of 10% to lyse the cells and precipitate 
proteins in the medium and from the lysed cells. The tube was centrifuged at 800 x 
g for 20 min. The supernatant was discarded and saved the pellet. To the pellet, 1.0 
ml of 10% trichloroacetic acid was added to wash away the non-incorporated labeled 
proline. This procedure was repeated at least for 2 times. At last centrifugation, the 
pellet was dissolved in 400 of NaOH (0.2 N) at 42 °C for 10 min. The aliquots 
(200 /tl) of dissolved solution was added to a vial containing 5 ml scintillation liquid 
(ScintiVerse BD, Fisher Scientific, SX18-4); the vial was counted for 5 min by beta-
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counter (Packard TRI-CARB 300, Downers Grove, IL). Background was subtracted, 
the radioactivities were expressed as counts per minute (CPM). 
Statistical analysis 
The experimental unit was 5 x 10^ cells/tube. The data are expressed as the 
mean ± SE of the counts per minute (CPM) without subtraction of the nonspecific 
binding. The treatment effects of hormones on proline incorporation were an­
alyzed by the General Linear Models Procedure of the Statistical Analysis System 
(SAS, 1985), followed by the least square difference (Snedecor and Cochran, 1989). 
P < 0.05 was considered significant. 
108 
RESULTS 
Effects of incubation time on the rate of incorporation of tritiated proline by 
uterine cervical cells with estradiol benzoate (EB 1.0 nM) are presented in Figure 
1. After 2 hr incubation, the cells incorporated 714 ± 23 CPM. At 6 hr, CPM rose 
to 819 ± 44. The maximal incorporation was reached at 8 hr. At 16 hr, CPM 
declined. Thus, the following incubation was carried out for 8 hr throughout the 
whole experiment. 
Figure 2 indicates that the effects of relaxin in doses from 0.0, 1.0, 100, 1000, 
10,000 nM on the rate of incorporation of ^H-proline by the uterine cervical cells. 
With an increase in the dose of relaxin, the cells incorporated more ^H-proline. At 
the doses of 100 nM, 1 /iM, 10 fiM, a significant effect was obtained (P < 0.05). With 
10 /iM of relaxin, the CPM of the incorporated ^H-proline by the cells was 1390 ± 
124 compared with the value of 970 ± 40 in the control. 
In the presence of 100 nM RU 486, progesterone increased (P < 0.05) the rate 
of ^H-proline incorporation into protein by cultured porcine uterine cervical cells 
only when progesterone concentrations were equal to or greater than 100 nM (Figure 
3). At the dose of 10,000 nM progesterone, the CPM of ^H-proline incorporated 
is 1250 ± 121 compared with 871 ± 53 at dose of 1.0 nM. RU 486 antagonized the 
stimulatory effects of progesterone on the rate of ^H-proline incorporation by porcine 
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uterine cervical ceils (Figure 4). In the presence of 100 nM progesterone, RU 486 
gradually reduced the CPM of ^H-proline incorporated in a dose-dependent manner. 
At dose of 10,000 nM, RU 486 significantly (P < 0.05) decreased the CPM to 854 
± 86 compared with 1701 ± 380 when RU 486 was 1.0 nM. The nonspecific binding 
(i.e., without cells or with lysed cells) averaged 327 ± 62. 
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Figure 1: Effect of incubation time with estradiol benzoate (EB 1.0 nM) on incor­
poration of tritiated proline into protein by porcine uterine cervical cells 
(5x10^ cells/tube). Values are mean ± pooled SE, each bar represents 6 
determinations of 2 separate experiments. 
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Figure 2: Effect of relaxin dosage on incorporation of tritiated proline into protein 
by porcine uterine cervical cells (8 h incubation; 5x10^ cells/tube). Values 
are mean ± pooled SE, each bar represents 9 determinations of 3 separate 
experiments, a: P < 0.05 compared with the value at 0 nM. 
112 
2500 n 
2000-
a 1500-
1000-
500-
1 1 0 1 0 0  1 0 0 0  1 0 0 0 0  
Progesterone (nM) 
Figure 3: Effect of progesterone dosage in the presence of 100 nM RU 486 on incor­
poration of tritiated proline into protein by porcine uterine cervical cells 
(8 h incubation; 5x10'^ cells/tube). Values are mean ± pooled SE, each 
bar represents 12 determinations of 4 separate experiments, a: P < 0.05 
compared with the value at 1 nM. 
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Figure 4: Effect of RU 486 dosage in the presence of 100 nM progesterone on incor­
poration of tritiated proline into protein by porcine uterine cervical cells 
(8 h incubation; 5x10^ cells/tube). Values are mean ± pooled SE, each 
bar represents 9 determinations of 3 separate experiments, a: P < 0.05 
compared with the value at 1 nM, 
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DISCUSSION 
Progesterone receptor antagonist, RU 486, is well documented for its efficacy 
in inducing abortion during the early pregnancy (Philibert et al., 1985; Couzinet et 
al., 1986; Shoupe et al., 1987). The accompanied effects on the cervical softening 
and dilation are identified to be specific for RU 486 (Wolf et al., 1989). The present 
study demonstrates that RU 486 antagonizes the stimulatory effects of progesterone 
on ^H-proline incorporation by porcine uterine cervical cells. This finding provides a 
possible explanation for the mechanism of the cervical softening and dilating induced 
by RU 486 in clinical observations (Radestad et al., 1988; Wolf et al., 1989). 
Both progesterone and relaxin increase the rate of ^H-proline incorporation by 
cultured uterine cervical cells. This finding lends support to the idea that relaxin 
may regulate collagen metabolism in inducing cervical softening during late preg­
nancy. The rate of ^H-proline incorporation can be considered to be a reliable index 
of collagen synthesis since proline is an important constituent of collagen, and the 
precursor of hydroxyproline, an unique amino acid, in collagen. The synthesis of 
collagen with altered physical properties occurs during the cervical maturation and 
softening (Weiss et al., 1979; Downing and Sherwood, 1986), this is also supported 
by the fact that the total content of collagen in the cervix at term increases, while 
the concentration of collagen decreases (Harkness and Harkness, 1959; Hollingsworth, 
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1981; Fosang et al., 1984). The increase in total collagen content paralleled the rising 
concentrations of relaxin and estrogen (Eldridge-White et al., 1989) in peripheral 
plasma. 
The contributions and specific roles of progesterone and relaxin on the colla­
gen metabolism are much different in vivo although both hormones have anabolic 
effects on collagen metabolism as shown in this in vitro study. First, cervical mat­
uration and softening occur when progesterone concentrations decline (progesterone 
withdrawal), while relaxin levels elevate (Anderson, 1987; Sherwood, 1988). Further­
more, progesterone was reported to inactivate the actions and abolish the production 
of collagenase (Jeffrey et al., 1971); relaxin stimulates the production of collagenase 
(Weiss et al., 1979; Too et al., 1984). Collagenase is, at least partially, responsible for 
the degradation and modification of the existing collagen matrix to induce cervical 
softening and dilatation during late pregnancy (Wahl et al., 1977; Too et al., 1986). 
It seems a paradox that both RU 486 and relaxin can induce cervical softening, 
but RU 486 suppresses collagen synthesis while relaxin stimulates collagen synthesis. 
Relaxin and RU 486 must use different mechanisms to mediate their effects on induc­
ing cervical softening. The effects of RU 486 on cervical softening observed in clinical 
subjects and experimental animals probably result by antagonizing the actions of 
progesterone on the uterus and cervix, and/or reducing progesterone levels and thus 
convert the uterus and cervix from refractory organs to sensitive organs to respond 
to stimulatory actions of prostaglandins, oxytocin and relaxin. Cervical softening 
can be induced by the administration of prostaglandin E2 (PGEg), prostaglandin 
F2Q: (PGF2Û:), and their analogs to intact rats on day 18 (HoUingsworth et al., 1980; 
Williams et al., 1983). PGE2 acts directly on the cervix, whereas PGFga may pro­
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moting cervical softening indirectly via its luteolytic effect on the ovaries to reduce 
progesterone production and secretion. The effects of RU 486 may be mediated by 
prostaglandins since RU 486 increases prostaglandin production in short-term cul­
ture of endometrial cells (Kelly et al., 1984, 1986) and in decidual glandular cells 
obtained from early pregnancy in humans (Smith and Kelly, 1987). Alternatively, 
the effect of RU 486 on cervical softening may be mediated by inducing relaxin secre­
tion from the corpora lutea because administration of RU 486 orally to late pregnant 
pigs induced earlier parturition, advanced the surge release of relaxin 2 days earlier 
with a greater amplitude of relaxin released into the peripheral blood compared with 
placebo treated controls (Li, et al., 1991a, 1991b). 
Cervical softening involves an interplay of estrogen, progesterone, prostaglandins, 
and relaxin (Kroc et al., 1959; Steinetz et al., 1980, 1983, 1985; Anderson, 1987; Sher­
wood, 1988). Cautions should be taken in the interpretation of the present results, 
since data from the in vitro model of cultured dispersed cells reflect, at best, only 
the direct effect of hormones on the cells and secondary to interactive effects which 
is lacking in this model. Furthermore, the cells which were obtained from cyclic 
pigs during the luteal phase may not behave the same as those cells from pigs in 
late pregnancy. In conclusion, the present results indicate that relaxin and RU 486 
can regulate collagen metabolism likely by different mechanisms to promote cervical 
softening as observed in clinical practice and animal experiments. 
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SUMMARY AND DISCUSSION 
The first section was designed to investigate the regulatory mechanism of relaxin 
and progesterone secretion from aging corpora lutea of hysterectomized gilts, espe­
cially concerning the roles of insulin-like growth factor I, luteinizing hormone and 
prolactin on secretion of relaxin and progesterone. The second, third, and fourth 
sections were conducted to determine actions and mechanism of relaxin and ovarian 
steroids on the growth and modification of connective tissues of the uterus and cervix. 
In section II, it was demonstrated that relaxin with or without estrogen accelerated 
the growth and development of the uterine cervix in prepubertal gilts. In section III, 
experiments were designed to delineate the role of estrogen in regulating the number 
of relaxin receptors and the synergistic interaction of relaxin with estrogen on colla­
gen and noncollagen synthesis and secretion from the uterine cervical cells. Section 
IV was carried out to determine the effects of progesterone, RU 486, and relaxin on 
the rate of incorporation of ^H-proline into collagen by the cervical cells. 
The corpora lutea of the pig can live in several different length of lifespans 
(about 18 days during the estrous cycle, 114 days during pregnancy, and more than 
150 days after hysterectomy). The main functions of these sex endocrine organs 
are to produce and secrete relaxin and progesterone. In pigs, relaxin is produced 
throughout pregnancy but little is released from the ovaries until 2 to 3 days before 
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parturition when massive amounts of relaxin are released into the peripheral blood 
circulation. The sharp increase in relaxin levels (designated antepartum relaxin surge) 
in blood plasma coincides with a simultaneous rapid decrease in progesterone blood 
levels. The underlying mechanism whereby this antepartum relaxin surge secretion 
and decreased progesterone secretion occurs is unknown. Hysterectomized pigs mimic 
the antepartum relaxin increase and progesterone decline as seen in pregnant pigs. 
Thus, they serve as a useful model to study hormonal regulation of luteal lifespan and 
function from days 110 to 116, a period when rapid changes occur in both pregnant 
and hysterectomized pigs. Insulin-like growth factor-I (IGF-I), luteinizing hormone 
and prolactin alone or in combination increased progesterone production by aging 
luteal tissues at day 110, but these tropic stimulatory actions were rapidly lost in 
the tissue from days 113 to 116. In contrast, relaxin release was stimulated by same 
treatments on days 110, and 113, and declined in day 116. This clearly indicates that 
luteal tissues from day 113 have two different mechanisms one for the polypeptide 
hormone, one for the steroid hormone secretion in response to the same hormonal 
challenge. These findings suggest, though do not prove, differentiated responses occur 
as a result of post receptor binding steps. Surge relaxin release may be related to aging 
of luteal cells and rapid decline in progesterone secretion may indicate functional 
luteolysis. Thus, these abrupt hormonal changes may be an indicator of ending of 
their lifespan. 
The primary physiological actions of relaxin are to prepare the birth canal for ac­
commodation of developing the conceptus(es) and facilitate delivery of the fetus(es). 
To determine role of relaxin on the growth and development of the uterus and cervix, 
an in vivo model of prepubertal gilts was used. The twenty littermates were assigned 
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randomly to four treatments: vehicle; relaxin; estrogen; and relaxin plus estrogen. In 
the presence of estrogen, relaxin accelerated growth and development of the uterus 
and cervix of prepubertal gilts. A treatment of six relaxin-estrogen injections (every 
other day with total 1 mg relaxin) induced a 4- to 5-fold increase in the wet weight, 
dry weight of the uterus and cervix compared with those vehicle-treated animals. 
The contents, but not the concentrations, of DNA, protein, and hydroxyproline (col­
lagen index) of the uterine cervix were significantly increased by relaxin plus estrogen 
treatments; this implies that tissue growth and development of the uterine cervix can 
be accelerated by appropriated hormonal stimulation such as relaxin and estrogen. 
It has been proved that the biological effects of relaxin on the uterine cervix and-
interpubic ligament are dependent upon estrogen priming. However, the mechanism 
whereby estrogen enables relaxin to exert its biological actions remain largely un­
known. In section III, a synergistical interaction of relaxin with estrogen was found 
by using a radioreceptor assay and primary culture of uterine cervical cells. In a time-
and dose-dependent manner, estrogen increased the number of relaxin binding sites 
on the cultured porcine uterine cervical cells as determined by a specific binding of 
a saturated dose of ^^^I-labeled monotyrosylated relaxin under optimal conditions. 
The Scatchard plot exhibited downward curvilinearity which implied that there are 
two classes of relaxin binding sites on these cells. The secretion of hydroxyproline 
from these cervical cells was synergistically stimulated by relaxin and estrogen; this 
stimulation was blocked by co-treatments of actinomycin D or cycloheximide. These 
results indicate that relaxin-estrogen induced collagen secretion is a process requiring 
RNA and protein de novo synthesis. 
RU 486, an antiprogesterone, is capable of inducing cervical softening, but little 
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is known about the mechanism(s) by which this hormone affects collagen metabolism 
of the cervix. The modification in collagen metabolism and architecture of connective 
tissues play a key role in softening and dilation of the cervix. The collagen consists 
of up to 80% protein in the cervix, and proline is a predominant amino acid and the 
precursor of hydroxyproline in collagen. Thus, the rate of ^H-proline incorporation 
can be considered to be a reliable index of collagen synthesis. In section IV, exper­
iments were designed to determine the effects of RU 486, progesterone, and relaxin 
on the rate of ^H-proline incorporation into the cultured uterine cervical cells of the 
pig. Collagenase-dispersed cells (5 x 10^ cells/tube) from the uterine cervix of gilts in 
luteal phase were incubated for 8 hr with (1) graded doses of progesterone (1 - 10,000 
nM) in the presence of 100 nM RU 486, (2) graded doses of RU 486 (1 - 10,000 nM) in 
the presence of 100 nM progesterone, (3) relaxin (1 - 10,000 nM). RU 486 antagonized 
the stimulatory effect of progesterone on the rate of ^H-proline incorporation. In a 
dose-dependent manner, relaxin increases (P < 0.05) the rate of ^H-proline incorpo­
ration. These results provide a possible explanation of mechanism by which RU 486 
and relaxin regulate collagen metabolism, leading to cervical softening as observed 
in the clinical subjects and experimental animals. 
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APPENDIX A. 
GLOSSARY OF TERMS (SECTION I) 
IGF50 = INSULIN-LIKE GROWTH FACTOR I (50 ng/ml); 
IGF300 = IGF (300 ng/ml); 
LHIOO = LUTEINIZING HORMONE (100 ng/ml); 
PRLIOO = PROLACTIN (100 ng/ml); 
TP = TISSUE PROGESTERONE (ng/mg tissue); 
MP = MEDIUM PROGESTERONE (ng/mg tissue); 
NP = NET PROGESTERONE (ng/mg tissue); 
TR = TISSUE RELAXIN (ng/mg tissue); 
MR = MEDIUM RELAXIN (ng/mg tissue); 
NR = NET RELAXIN (ng/mg tissue); 
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Table A.l: Mean concentrations of relaxin in the medium secreted by porcine luteal 
tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MRLX 
3003 110 GNTL 1074 
3003 110 IGF50 1615 
3003 110 IGF300 1255 
3003 110 LHIOO 1556 
3003 110 LHIOOO 1500 
3003 110 PRLIOO 1285 
3003 110 PRLIOOO 1340 
3003 110 PRLLH 1305 
3003 110 PRLIGF 1866 
3003 110 LHIGF 1392 
3003 110 LHPRLIGF 1392 
3051 110 CNTL 1927 
3051 110 IGF50 2111 
3051 110 IGF300 2074 
3051 110 LHIOO 1858 
3051 110 LHIOOO 2209 
3051 110 PRLIOO 2212 
3051 110 PRLIOOO 2089 
3051 110 PRLLH 2139 
3051 110 PRLIGF 2364 
3051 110 LHIGF 2053 
3051 110 LHPRLIGF 2118 
3151 110 CNTL 891 
3151 110 IGF50 835 
3151 110 IGF300 975 
3151 110 LHIOO 906 
3151 110 LHIOOO 813 
3151 110 PRLIOO 908 
3151 110 PRLIOOO 932 
3151 110 PRLLH 873 
3151 110 PRLIGF 1028 
3151 110 LHIGF 958 
3151 110 LHPRLIGF 1028 
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Table A.2: Mean concentrations of relaxin in the medium secreted by porcine luteal 
tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MRLX 
3082 110 CNTL 1902 
3082 110 IGF50 2006 
3082 110 IGF300 1489 
3082 110 LHIOO 1747 
3082 110 LHIOOO 1563 
3082 110 PRLIOO 1763 
3082 110 PRLIOOO 1604 
3082 110 PRLLH 1831 
3082 110 PRLIGF 1811 
3082 110 LHIGF 2241 
3082 110 LHPRLIGF 2086 
2992 110 CNTL 1345 
2992 110 IGF50 1600 
2992 110 IGF300 1727 
2992 110 LHIOO 1523 
2992 110 LHIOOO 1546 
2992 110 PRLIOO 1706 
2992 110 PRLIOOO 1608 
2992 110 PRLLH 1501 
2992 110 PRLIGF 1523 
2992 110 LHIGF 1696 
2992 110 LHPRLIGF 1384 
2990 113 CNTL 2521 
2990 113 IGF50 2609 
2990 113 IGF300 2406 
2990 113 LHIOO 2460 
2990 113 LHIOOO 2323 
2990 113 PRLIOO 2140 
2990 113 PRLIOOO 2693 
2990 113 PRLLH 2197 
2990 113 PRLIGF 2887 
2990 113 LHIGF 2346 
2990 113 LHPRLIGF 2589 
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Table A.3: Mean concentrations of relaxin in the medium secreted by porcine luteal 
tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MRLX 
3004 113 CNTL 1052 
3004 113 IGF50 1002 
3004 113 IGF300 1155 
3004 113 LHIOO 972 
3004 113 LHIOOO 1137 
3004 113 PRLIOO 988 
3004 113 PRLIOOO 945 
3004 113 • PRLLH 1326 
3004 113 PRLIGF 1035 
3004 113 LHIGF 943 
3004 113 LHPRLIGF 1021 
3012 113 CNTL 659 
3012 113 IGF50 592 
3012 113 IGF300 475 
3012 113 LHIOO 521 
3012 113 LHIOOO 593 
3012 113 PRLIOO 654 
3012 113 PRLIOOO 536 
3012 113 PRLLH 495 
3012 113 PRLIGF 496 
3012 113 LHIGF 651 
3012 113 LHPRLIGF 657 
3090 113 CNTL 1489 
3090 113 IGF50 2066 
3090 113 IGF300 4106 
3090 113 LHIOO 3573 
3090 113 LHIOOO 1900 
3090 113 PRLIOO 2333 
3090 113 PRLIOOO 3284 
3090 113 PRLLH 2032 
3090 113 PRLIGF 3510 
3090 113 LHIGF 5313 
3090 113 LHPRLIGF 3517 
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Table A.4: Mean concentrations of relaxin in the medium secreted by porcine luteal 
tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MRLX 
2973 113 CNTL 1030 
2973 113 IGF50 1439 
2973 113 IGF300 965 
2973 113 LHIOO 1224 
2973 113 LHIOOO 1329 
2973 113 PRLIOO 1369 
2973 113 PRLIOOO 1246 
2973 113 PRLLH 1001 
2973 113 PRLIGF 1018 
2973 113 LHIGF 1619 
2973 113 LHPRLIGF 1845 
2952 116 CNTL 828 
2952 116 IGF50 839 
2952 116 IGF300 837 
2952 116 LHIOO 863 
2952 116 LHIOOO 719 
2952 116 PRLIOO 703 
2952 116 PRLIOOO 794 
2952 116 PRLLH 968 
2952 116 PRLIGF 718 
2952 116 LHIGF 923 
2952 116 LHPRLIGF 917 
3114 116 CNTL 1255 
3114 116 IGF50 1498 
3114 116 IGF300 1555 
3114 116 LHIOO 1602 
3114 116 LHIOOO 1268 
3114 116 PRLIOO 1378 
3114 116 PRLIOOO 1604 
3114 116 PRLLH 1226 
3114 116 PRLIGF 1404 
3114 116 LHIGF 1488 
3114 116 LHPRLIGF 1343 
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Table A.5: Mean concentrations of relaxin in the medium secreted by porcine luteal 
tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MRLX 
3122 116 CNTL 918 
3122 116 IGF50 936 
3122 116 IGF300 743 
3122 116 LHIOO 573 
3122 116 LHIOOO . 
3122 116 PRLIOO 678 
3122 116 PRLIOOO 1009 
3122 116 PRLLH 607 
3122 116 PRLIGF 512 
3122 116 LHIGF 610 
3122 116 LHPRLIGF 781 
2960 116 CNTL 572 
2960 116 IGF50 
2960 116 IGF300 507 
2960 116 LHIOO 677 
2960 116 LHIOOO 579 
2960 116 PRLIOO 740 
2960 116 PRLIOOO 
2960 116 PRLLH 892 
2960 116 PRLIGF 802 
2960 116 LHIGF 629 
2960 116 LHPRLIGF 701 
2961 116 CNTL 1866 
2961 116 IGF50 2032 
2961 116 IGF300 3570 
2961 116 LHIOO 2405 
2961 116 LHIOOO 2208 
2961 116 PRLIOO 2350 
2961 116 PRLIOOO 1846 
2961 116 PRLLH 2234 
2961 116 PRLIGF 1988 
2961 116 LHIGF 2056 
2961 116 LHPRLIGF 2285 
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Table A.6: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
3003 110 CNTL 61.4 
3003 110 IGF50 71.2 
3003 110 IGF300 70.6 
3003 110 LHIOO 73.5 
3003 110 LHIOOO 61.2 
3003 110 PRLIOO 54.2 
3003 110 PRLIOOO 48.4 
3003 110 PRLLH 58.3 
3003 110 PRLIGF 57 
3003 110 LHIGF 55.4 
3003 110 LHPRLIGF 59 
3051 110 CNTL 27 
3051 110 IGF50 26 
3051 110 IGF300 24 
3051 110 LHIOO 47.4 
3051 110 LHIOOO 43.4 
3051 110 PRLIOO 58 
3051 110 PRLIOOO 52.6 
3051 110 PRLLH 58.6 
3051 110 PRLIGF 50.6 
3051 110 LHIGF 43 
3051 110 LHPRLIGF 44.6 
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Table A.7: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
3151 110 CNTL 27.6 
3151 110 IGF50 30 
3151 110 IGF300 33.4 
3151 110 LHIOO 27.8 
3151 110 LHIOOO 37.4 
3151 110 PRLIOO 27.4 
3151 110 PRLIOOO 24.2 
3151 110 PRLLH 45.6 
3151 110 PRLIGF 31.6 
3151 110 LHIGF 37 
3151 110 LHPRLIGF 29.6 
3082 110 CNTL 49.2 
3082 110 IGF50 47.3 
3082 110 IGF300 43.2 
3082 110 LHIOO 52.2 
3082 110 LHIOOO 47.9 
3082 110 PRLIOO 42 
3082 110 PRLIOOO 42.6 
3082 110 PRLLH 58.4 
3082 110 PRLIGF 48.7 
3082 110 LHIGF 61.2 
3082 110 LHPRLIGF 53.2 
2992 110 CNTL 17.5 
2992 110 IGF50 16.4 
2992 110 IGF300 15 
2992 110 LHIOO 16.4 
2992 110 LHIOOO 24.7 
2992 110 PRLIOO 26.1 
2992 110 PRLIOOO 20.4 
2992 110 PRLLH 17.7 
2992 110 PRLIGF 19.1 
2992 110 LHIGF 28.4 
2992 110 LHPRLIGF 20 
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Table A.8: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
2990 113 CNTL 29 
2990 113 IGF50 38 
2990 113 IGF300 29.7 
2990 113 LHIOO 38.3 
2990 113 LHIOOO 26.3 
2990 113 PRLIOO 29.3 
2990 113 PRLIOOO 32.0 
2990 113 • PRLLH 44.7 
2990 113 PRLIGF 53.3 
2990 113 LHIGF 37.3 
2990 113 LHPRLIGF 51 
3004 113 CNTL 28.7 
3004 113 IGF50 25.3 
3004 113 IGF300 28.7 
3004 113 LHIOO 30.3 
3004 113 LHIOOO 37.3 
3004 113 PRLIOO 27.3 
3004 113 PRLIOOO 27 
3004 113 PRLLH 38.7 
3004 113 PRLIGF 28.7 
3004 113 LHIGF 34 
3004 113 LHPRLIGF 32.7 
3012 113 CNTL 57.3 
3012 113 IGF50 59.7 
3012 113 IGF300 54.3 
3012 113 LHIOO 52 
3012 113 LHIOOO 61.7 
3012 113 PRLIOO 54 
3012 113 PRLIOOO 48 
3012 113 PRLLH 58.7 
3012 113 PRLIGF 44 
3012 113 LHIGF 47.3 
3012 113 LHPRLIGF 65.3 
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Table A.9: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
3090 113 CNTL 36.1 
3090 113 IGF50 35 
3090 113 IGF300 31.1 
3090 113 LHIOO 27.9 
3090 113 LHIOOO 4&8 
3090 113 PRLIOO 26.3 
3090 113 PRLIOOO 31.7 
3090 113 PRLLH 31.9 
3090 113 PRLIGF 27 
3090 113 LHIGF 27.2 
3090 113 LHPRLIGF 32.3 
2973 113 CNTL 21.2 
2973 113 IGF50 22.8 
2973 113 IGF300 31.9 
2973 113 LHIOO 28.1 
2973 113 LHIOOO 24 
2973 113 PRLIOO 
2973 113 PRLIOOO 11.9 
2973 113 PRLLH 16.9 
2973 113 PRLIGF 18.2 
2973 113 LHIGF 19.3 
2973 113 LHPRLIGF 13.4 
2952 116 CNTL 47.5 
2952 116 IGF50 45.3 
2952 116 IGF300 50.8 
2952 116 LHIOO 52.8 
2952 116 LHIOOO 53.7 
2952 116 PRLIOO 40.4 
2952 116 PRLIOOO 45.1 
2952 116 PRLLH 35.3 
2952 116 PRLIGF 31.6 
2952 116 LHIGF 38.6 
2952 116 LHPRLIGF 32,6 
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Table A.10: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
3114 116 CNTL 33.4 
3114 116 IGF50 32.8 
3114 116 IGF300 .32.7 
3114 116 LHIOO 28.4 
3114 116 LHIOOO 29.8 
3114 116 PRLIOO 25.3 
3114 116 PRLIOOO 26.3 
3114 116 PRLLH 27.9 
3114 116 PRLIGF 30.5 
3114 116 LHIGF 28.5 
3114 116 LHPRLIGF 23.1 
3122 116 CNTL 20.3 
3122 116 IGF50 24.6 
3122 116 IGF300 19.1 
3122 116 LHIOO 24.8 
3122 116 LHIOOO 20.1 
3122 116 PRLIOO 18.2 
3122 116 PRLIOOO 21 
3122 116 PRLLH 
3122 116 PRLIGF 
3122 116 LHIGF 29.1 
3122 116 LHPRLIGF 27.4 
2960 116 CNTL 22.7 
2960 116 IGF50 18 
2960 116 IGF300 
2960 116 LHIOO 22.0 
2960 116 LHIOOO 19.5 
2960 116 PRLIOO 22.1 
2960 116 PRLIOOO 18.1 
2960 116 PRLLH 23.9 
2960 116 PRLIGF 18.1 
2960 116 LHIGF 16.1 
2960 116 LHPRLIGF 14.0 
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Table A.11: Mean concentrations of progesterone in the medium secreted by porcine 
luteal tissue removed from hysterectomized pig (ng/mg tissue) 
PIG NO. DAY TREATMENT MP4 
2961 116 CNTL 15.8 
2961 116 IGF50 22.7 
2961 116 IGF300 21.8 
2961 116 LHIOO 24.5 
2961 116 LHIOOO 20.4 
2961 116 PRLIOO 35.7 
2961 116 PRLIOOO 29.3 
2961 116 PRLLH 19.2 
2961 116 PRLIGF 30.4 
2961 116 LHIGF 25.4 
2961 116 LHPRLIGF 26.2 
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Table A.12; Mean concentrations (n = 3) of relaxin in the porcine luteal tissue after 
8 h incubation from hysterectomized gilts (ng/ml) • 
DAY Treatment/Gilt No G3003 G3051 G3151 G3082 G2992 
DUO CNTL 2524 1976 1814 914 2994 
DUO IGF50 2096 2135 2023 944 3620 
DUO IGF300 2909 1829 1912 981 3446 
DUO LHIOO 3105 2093 2542 664 2877 
DUO LHIOOO 3088 2105 2608 989 2619 
DUO PRLIOO 2349 1926 2425 983 3605 
DUO PRLIOOO 2896 2014 2269 1101 3827 
DUO PRL+LH 2939 1754 2487 1187 3210 
DUO IGF+PRL 2612 1766 2020 1285 4484 
DUO IGF+LH 3532 1612 2583 1664 3644 
DUO IGF+PRL+LH 7481 1996 2554 3302 4666 
DAY Treatment/Gilt No G2990 G3004 G3012 G3090 G2973 
DU3 CNTL 1401 1359 1711 2212 2287 
DU3 IGF50 1581 1031 2275 2150 1959 
DU3 IGF300 1384 1301 2090 2262 1521 
DU3 LHIOO 1400 1494 1794 2032 1713 
DU3 LHIOOO 1781 849 2004 2877 3583 
DU3 PRLIOO 1657 719 2568 2522 2082 
DU3 PRLIOOO 1851 1100 1391 2700 3217 
D113 PRL+LH 1695 924 2034 2757 2654 
DU3 IGF+PRL 1235 931 1810 2742 2196 
DU3 IGF+LH 2338 1022 2098 3256 2921 
DU3 IGF+PRL+LH 3451 843 1423 2412 
DAY Treatment/Gilt No G2952 G3U4 G3122 G2960 G2961 
DU6 CNTL 1293 2751 1640 1497 2810 
D116 IGF50 1345 2841 1934 1338 2569 
DU6 IGF300 1308 3152 1325 1676 1810 
DU6 LHIOO 1154 3591 1173 1486 3172 
DU6 LHIOOO 1597 2976 1426 1336 4110 
DU6 PRLIOO 1118 2793 1203 3740 
DU6 PRLIOOO 2964 1350 1214 2175 
DU6 PRL+LH 1395 3621 1278 1588 4303 
DU6 IGF+PRL 1338 4185 1030 2365 4668 
DU6 IGF+LH 1454 2744 1257 1899 3972 
DU6 IGF+PRL+LH 2121 2189 1381 1973 3921 
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Table A.13: Mean contents (n = 3) of progesterone in the porcine luteal tissue after 
8 h incubation removed from hysterectomized gilts (ng/ml) 
DAY Treatment/Gilt No G3151 G3051 (33003 G3082 G2992 
DUO CNTL 166 140 149 152 102 
DUO IGF50 197 135 176 150 89 
DUO IGF300 187 137 173 143 160 
DUO LHIOO 185 137 181 138 83 
DUO LHIOOO 268 125 142 133 98 
DUO PRLIOO 248 117 214 131 121 
DUO PRLIOOO 267 112 186 132 116 
DUO PRL+LH 279 93 162 116 136 
DUO IGF+PRL • 277 69 199 145 132 
DUO IGF+LH 260 114 186 212 115 
DUO IGF+PRL+LH 284 10 164 212 117 
DAY Treatment/Gilt No G2990 G3004 G3012 G3090 G2973 
D113 CNTL 129 108 116 145 134 
D113 IGF50 131 96 120 125 151 
DU3 IGF300 133 102 130 117 132 
DU3 LHIOO 125 114 111 133 139 
D113 LHIOOO 160 129 139 140 155 
D113 PRLIOO 171 98 120 119 130 
D113 PRLIOOO 163 109 152 129 106 
DU3 PRL+LH 180 118 173 124 109 
DU3 IGF+PRL 151 142 116 106 
DU3 IGF+LH 167 110 160 115 133 
DU3 IGF+PRL+LH 117 106 145 123 136 
DAY Treatment/Gilt No G2952 G3U4 G3122 G2960 G2961 
DU6 CNTL 108 125 150 161 143 
DU6 IGF50 143 173 140 134 124 
DU6 IGF300 140 130 134 118 144 
D116 LHIOO 121 125 133 175 161 
D116 LHIOOO 141 127 131 153 169 
DU6 PRLIOO 133 94 145 139 205 
Dlia PRLIOOO 151 133 128 120 151 
D116 PRL+LH 127 140 115 144 168 
D116 IGF+PRL 120 149 125 133 151 
DU6 IGF+LH 167 169 126 136 133 
DU6 IGF+PRL+LH 179 107 127 131 163 
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Table A.14: Net mean concentration (n = 15) of progesterone produced by porcine 
luteal tissue removed from hysterectomized gilts (ng/mg tissue) 
DAY Treatment TP MP TMP NP 
DUO CNTL 142 36.5 178.5 25.1 
DUO IGF50 150 38.2 188 35 
DUO IGF300 160 37.2 197.2 43.8 
DUO LHIOO 145 43.5 188.5 35.1 
DUO LHIOOO 153 42.9 196 42.5 
DUO PRLIOO 166 41.5 207 53.6 
DUO PRLIOOO 162 37.6 200 46.6 
DUO PRL+LH 157 47.7 205 51.3 
DUO IGF+PRL 164 41.4 205 56.6 
DUO IGF+LH 177 45 222 68.6 
DUO IGF+PRL+LH 177 41.3 219 65.4 
D113 CNTL 126 34.5 161 31 
D113 IGF50 124 36.2 160.6 31 
D113 IGF300 123 35.4 158.4 29 
D113 LHIOO 124.4 35.3 160 31 
D113 LHIOOO 144.3 38.6 183.6 54 
D113 PRLIOO 127.6 34.2 161.8 32 
D113 PRLIOOO 131 30.1 161.1 32 
D113 PRL+LH 141 3&2 179.2 50 
D113 IGF+PRL 129 34.2 163.2 34 
D113 IGF+LH 137 33 170 40.6 
D113 IGF+PRL+LH 125 38.9 164 35 
D116 CNTL 138 27.9 165.9 31.3 
D116 IGF50 143 28.7 171.7 37.1 
D116 IGF300 133 31.1 164.1 30 
D116 LHIOO 143 30.5 173.5 3&9 
D116 LHIOOO 143.8 28.7 172.5 37.9 
D116 PRLIOO 143.3 28.3 171.6 37 
D116 PRLIOOO 136.4 28 164.4 30 
D116 PRL+LH 139 26.6 105,6 31 
D116 IGF+PRL 136 27.6 163.6 29 
D116 IGF+LH 146 27.5 173.5 38.9 
D116 IGF+PRL+LH 141.4 24.7 166.1 31.4 
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Table A.15; Net mean concentrations (n = 15) of relaxin produced by porcine luteal 
tissue removed from hysterectomized gilts (ng/mg tissue) 
DAY Treatment MR TR TMR NR 
DUO CNTL 1427 2074 3501 26 
DUO IGF50 1633 2163 3821 346 
DUO IGF300 1504 2215 3719 244 
DUO LHIOO 1518 2256 3774 299 
DUO LHIOOO 1526 2281 3807 350 
DUO PRLIOO 1574 2257 3831 356 
DUO PRLIOOO 1514 2421 3935 460 
DUO PRL+LH 1529 2315 3816 329 
DUO IGF+PRL 1718 2433 4151 676 
DUO IGF+LH 1668 2607 4275 800 
DUO IGF+PRL+LH 1601 3999 5600 2125 
DU3 CNTL 1350 1794 3144 4 
DU3 IGF50 1541 1799 3340 200 
DU3 IGF300 1821 1712 3533 393 
DU3 LHIOO 1750 1686 3436 296 
DU3 LHIOOO 1456 2218 3674 534 
DU3 PRLIOO 1496 1909 3405 265 
DU3 PRLIOOO 1740 1997 3737 597 
DU3 PRL+LH 1410 2076 3486 346 
DU3 IGF+PRL 1789 1995 3784 644 
DU3 IGF+LH 2174 2327 4501 1361 
DU3 IGF+PRL+LH 1925 2032 3957 817 
DU6 CNTL 1087 2000 3087 -89 
DU6 IGF50 1326 2005 3331 155 
DU6 IGF300 1442 1854 3296 120 
DU6 LHIOO 1224 2115 3339 163 
DU6 LHIOOO 1194 2115 3309 133 
DU6 PRLIOO 1169 2213 3382 206 
D116 PRLIOOO 1313 1925 3238 62 
DU6 PRL+LH 1185 2437 3622 446 
DU6 IGF+PRL 1084 2517 3601 425 
DU6 IGF+LH 1141 2265 3406 230 
DU6 IGF+PRL+LH 1204 2317 3521 345 
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GLOSSARY OF TERMS OF THE SECTION II 
LITT = LITTer, A referred to a sow 
TRT = Treatment, RLX = relaxin, EB = estradiol benzoate 
TPROL = Total hydroxyproline 
TDNA = Total DNA content/cervix 
WETCV = Wet weight of the cervix 
TDRYU = Total dry weight of the uterus 
TDRYV = Total dry weight of the cervix 
WETU = Wet Weight of the Uterus 
PROV = protein content of the cervix 
WWUH = Wet Weight of the Uterine Horn 
PDWU = Percentage of Dry Weight of the Uterus 
PDWC = Percentage of Dry Weight of the Cervix 
DWUH = Dry Weight of the Uterine Horn 
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Table A.16: Data of relaxin and estrogen on the growth and development of the 
uterine cervix of prepubertal gilts (I) 
LITT TRT TPROL TDNA WETCV TDRYU TDRYV WETU 
A CNTL 6.83 1.97 2.7 4.32 .459 25.7 
B CNTL 9.10 0.92 2.0 2.89 .348 18 
C CNTL 6.01 1.61 3.1 5.10 .577 30 
D CNTL 12.2 1.53 2.5 5.20 .573 29 
E CNTL 28.8 4.32 6.0 5.44 .96 38 
A RLX 8.86 2.63 3.5 6.5 .665 38.2 
B RLX 14.6 1.54 2.8 4.26 .479 26.6 
C RLX 16.3 1.58 2.4 4.2 .37 24 
D RLX 9.45 1.13 2.5 7.51 .458 46 
E RLX 40.5 5.22 9.0 7.92 1.62 44 
A EB 12.9 3.4 4.1 7.0 .656 41.2 
B EB 28.1 2.64 5.5 9.12 1.24 56 
C EB 50.4 4.6 7.0 13.6 1.49 80 
D EB 87.5 6.9 16.5 28.4 3.5 172 
E EB 57.0 9.5 15 14 3.15 75 
A RLXEB 22.1 4.5 5.0 8.43 .8 48.6 
B RLXEB 49.4 4.2 9.6 18.1 2.2 100 
C RLXEB 76.7 5.45 10.1 20.3 2.1 115 
D RLXEB 119 10.7 20.1 41.7 4.36 246 
E RLXEB 189 15.4 29 29.8 5.8 170 
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Table A.17: Data of relaxin and estrogen on the growth and development of the 
uterine cervix of prepubertal gilts (II) 
LITT PIG TRT WWUH PDWU PDWC DWUH PROV 
A 1001 CNTL 32 14 16 4.48 306 
B 3141 CNTL 23 16.8 17 3.86 110 
C 0439 CNTL 16 15.9 17.4 2.54 122 
D 0414 CNTL 27 . 17.3 22.9 4.59 208 
E 0455 CNTL 26.5 17.3 23 4.56 203 
A 1004 RLX 35 18 18 6.3 567 
B 3142 RLX 34.7 17 19 5.9 138 
C 0432 RLX 23.8 15.9 17.1 3.78 192 
D 0412 RLX 21.6 17.5 15.4 3.78 181 
E 0454 RLX 43.5 16.2 18.3 7.1 140 
A 1000 EB 60 18 21 10.8 795 
B 3144 EB 37.1 17 16 6.3 168 
C 0433 EB 50.5 15.6 22.5 7^ 8 424 
D • 0411 EB 73 16.6 21.3 12.1 588 
E 0452 EB 155.5 16 21.2 24.88 1666 
A 1003 RLXEB 141 17 20 5.8 1682 
B 3153 RLXEB 43.6 17.5 16 7.63 187 
C 0434 RLXEB 90.4 17.6 22.5 15.9 833 
D 0413 RLXEB 105 17.3 20.5 18.2 820 
E 0450 RLXEB 226 16.5 21.7 37.3 1375 
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GLOSSARY OF TERMS (SECTION III) 
EB = estradiol benzoate 
RLX — relaxin 
EB50 = estradiol benzoate 50 ng/ml 
CYCLO = cycloheximide 500 ng/ml 
ACT-D = actinomycin D 500 ng/ml 
ACTINOMYCIN = actinomycin D 500 ng/ml 
cAMPO.l mM = cyclic cAMP in 0.01 mM 
CONTROL = no hormone added 
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A.18: Effects of time course and EB dose (ng/ml) on relaxin binding by 
porcine uterine cervical cells (CPM) 
NO/TIME 0.0 2 HR 4 HR 6HR 8 HR 16 HR 
1 2321 3770 4163 3242 4951 4212 
2 2430 3901 3554 3503 5853 4544 
3 2508 3562 3706 3680 5610 3607 
4 721 1919 2195 2367 4711 5908 
5 969 2134 2576 4004 5920 3259 
6 1493 1507 2999 3576 5018 2970 
NO/Dosage (ng/ml) 0.0 0.4 2 10 50 250 
1 3795 4863 4941 4777 4886 4383 
2 3265 4523 3979 4405 4223 5099 
3 3614 4404 5440 5675 4419 5037 
4 1844 2291 2099 2443 2765 2246 
5 1774 2538 2568 2428 3725 2630 
6 2555 2719 3226 3471 2784 2036 
164 
Table A. 19: Competitive binding of the unlabeled relaxin over the labeled relaxin 
by porcine uterine cervical cells 
TUBE NO RELAXIN BOUND(CPM) % of MAXIMAL BINDING 
1 0 3769 
2 0 4015 100 
3 0 4736 
4 1 2119 
5 1 640 49.2 
6 1 1987 
7 10 1858 
8 10 1890 44.3 
9 10 2998 
10 100 1693 
11 100 1793 41.0 
12 100 1635 
13 1000 1422 
14 1000 1535 34.8 
15 1000 1403 
16 10000 1671 
17 10000 1627 32.3 
18 10000 1346 
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Table A.20: Data of the Scatchard plot of relaxin binding by porcine uterine cervical 
cells (RRA 1) 
LABELED RLX (CPM) RLX BOUND (CPM) BOUND (fM) B/F 
8,000,000 208299 42.95 0.0267 
800,000 19485 4.018 0.2496 
80,000 1885 0.388 0.3080 
4000 982 0.202 0.3250 
800 552 0.114 2.2250 
Table A.21: Data of the Scatchard plot of relaxin binding by porcine uterine cervical 
cells (RRA 2) 
LABELED RLX (CPM) RLX BOUND (CPM) BOUND (fM) B/F 
800,000 57883 11.94 0.071 
400,000 28213 5.820 0.076 
200,000 12010 2.480 0.064 
80,000 5417 1.130 0.073 
40,000 3297 0.680 0.090 
8000 827 0.160 0.112 
800 156 0.032 0.242 
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Table A.22: Hydroxyproline concentration secreted by porcine uterine cervical cells 
(3x10^ cells/well) after 48 incubation, ^g/ml 
Treatment/Pig No. G0253 G0380 G0184 MEAN SD 
CONTROL 14.3 11.4 14.8 13.5 1.8 
RLXEB 17.8 15.2 18.1 17.0 1.6 
RLXEB+CYCLO 12.5 13.5 12.6 12.9 0.6 
RLXEB+ACT-D 13.8 13.8 9.5 12.4 2.5 
ACTINOMYCIN 12.2 13.1 7.8 11.0 2.8 
cAMPO.lnaM 17.7 21.0 18.4 19 1.7 
cAMPl.OmM 21.4 21.0 19.8 . 20.7 0.8 
cAMP5.0mM 37.1 41.0 33.8 37.3 3.6 
Treatment/Pig No. G2833 02873 2872 (32940 G2941 
CONTROL 11.5 15.4 19.1 12.7 8.2 
EB50 11.6 14.9 17.9 14.0 8.0 
EB250 12.6 14.0 19.6 23.4 9.4 
RLXlOO 12.6 12.8 20.3 10.8 10.0 
RLX500 10.1 13.0 20.3 11.7 8.3 
E50R100 12.8 18.8 22.6 23.0 13.4 
E50R500 21.9 14.0 20.4 25.9 19.1 
E250R100 18.1 14.8 27.0 19.4 18.2 
E250R500 15.8 13.6 24.1 29.3 9.90 
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Table A.23: Protein concentration secreted by porcine uterine cervical cells (3x10^ 
cells/well) after 48 incubation, /tg/ml 
Treatment/Pig No. G2833 G2873 2872 G2940 G2941 
CONTROL 128.5 126.2 127.8 152.7 
EB50 173.3 158.5 139.1 160.1 106.4 
EB250 178.6 184.3 113.3 171.1 152.9 
RLXlOO 191.2 211.7 150.4 169.7 287.2 
RLX500 187.6 219.8 153.6 178.4 214.3 
E50R100 191.2 168.2 197.2 176.1 333.2 
E50R500 191.2 184.3 171.4 185.8 261.9 
E250R100 185.9 276.2 221.4 194.5 189.1 
E250R500 190.0 181.1 160.1 204.0 132.3 
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GLOSSARY OF TERMS (SECTION IV.) 
TRT = treatment 
NMl = 1.0 nano mole 
NMIO = 10.0 nano mole 
NMIOO = 100 nano mole 
UMl = 1.0 micro mole 
UMIO = 10 micro mole 
CNTL = control 
2HR = 2 hours of incubation 
CPMP4 = counts per minute of progesterone treatment 
CP MRU = counts per minute of RU 486 treatment 
CPMRLX = counts per minute of relaxin treatment 
169 
Table A.24: Counts per minute of the tritiated proline incorporated into protein by-
porcine uterine cervical cells (5x10 cells/tube) after 8 h incubation 
PIG TRT CPMP4 CPMRU CPMRLX 
837 NMl 548 991 821 
837 NMl 625 1747 1948 
837 NMl 875 1259 1404 
837 NMIO 851 1005 1068 
837 NMIO 846 569 1383 
837 NMIO 911 1098 1147 
837 NMIOO 754 713 1266 
837 NMIOO 1149 790 1045 
837 NMIOO 1467 967 1933 
837 UMl 792 1505 
837 UMl 1553 1110 819 
837 UMl 2059 891 962 
837 UMIO 1606 665 989 
837 UMIO 812 
837 UMIO 471 2075 
805 NMl 1050 1255 787 
805 NMl 729 1154 672 
805 NMl 1161 765 664 
805 NMIO 636 1009 627 
805 NMIO 757 781 1142 
805 NMIO 696 969 714 
805 NMIOO 1044 804 1121 
805 NMIOO 1481 567 1652 
805 NMIOO 1059 727 775 
805 UMl 743 916 2065 
805 UMl 1243 1257 1420 
805 UMl 1244 806 1891 
805 UMIO 663 996 1661 
805 UMIO 1432 1259 1184 
805 UMIO 851 768 1461 
170 
Table A.25: Counts per minute of the tritiated proline incorporated into protein by 
porcine uterine cervical cells (5x10^ cells/tube) after 8 h incubation 
PIG TRT CPMP4 CPMRU CPMRLX 
947 NMl 1012 4588 796 
947 NMl 1012 1888 1220 
947 NMl 956 1660 876 
947 NMIO 816 1018 1372 
947 NMIO 1232 3674 1352 
947 NMIO 1120 2206 1104 
947 NMIOO 900 3384 1108 
947 NMIOO 2244 768 1252 
947 NMIOO 2604 872 1656 
947 UMl 1348 1192 1160 
947 UMl 1268 1092 964 
947 UMl 1108 1148 1172 
947 UMIO 1084 832 1408 
947 UMIO 1440 1056 1352 
947 UMIO 1512 788 1568 
947 CNTL 1000 1000 1000 
805 CNTL 1072 1072 1072 
837 CNTL 1064 1064 1064 
947 CNTL 812 812 812 
805 CNTL 908 908 908 
837 CNTL 968 968 968 
837 2HR 698 698 698 
837 2HR 597 597 597 
837 2HR 685 685 685 
837 4HR 735 735 735 
837 4HR 609 609 609 
837 4HR 772 772 772 
837 6HR 734 734 734 
837 6HR 688 688 688 
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Table A.26: Counts per minute of the tritiated proline incorporated into protein by 
porcine uterine cervical cells after 8 h incubation 
PIG TRT CPMP4 CPMRU RLX 
837 6HR 840 840 840 
837 8HR 1143 1143 1143 
837 8HR 942 942 942 
837 8HR 798 798 798 
837 16HR 731 731 731 
837 16HR 827 827 827 
805 2HR 687 687 687 
805 2HR 760 760 760 
805 2HR 849 849 849 
805 4HR 824 824 824 
805 4HR 799 799 799 
805 4HR 606 606 606 
805 6HR 1291 1291 1291 
805 6HR 883 883 883 
805 6HR 714 714 714 
805 8HR 981 981 981 
805 8HR 783 783 783 
805 16HR 646 646 646 
805 16HR 466 466 466 
804 NMl 708 708 708 
804 NMl 853 853 853 
804 NMl 921 921 921 
804 NMIO 820 820 820 
804 NMIO 918 918 918 
804 NMIO 990 990 990 
804 NMIOO 698 698 698 
804 NMIOO 1007 1007 1007 
804 UMl 1426 1426 1426 
804 UMl 795 795 795 
804 UMIO 1410 . . 
